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„Bones can break, muscles 
atrophy, glands can loaf, even the 
brain can go to sleep, without 
immediately endangering our 
survival, but when the kidneys fail 
to manufacture the proper kind of 
blood neither bone, muscle, gland 
or brain can carry on.” 
Homer W. Smith, From Fish to Philosopher 
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Abstract 
The secretion and synthesis of renin is regulated by several systemic and local factors. 
Besides salt balance, extracellular volume and blood pressure, different hormones such as 
ANG II, arginine vasopressin and norepinephrine were examined as renin mediators. 
Moreover, endothelins have been hypothesized as negative regulators of renin secretion and 
synthesis in vitro whereas they have been suggested to primarily inhibit the release of renin 
through a high cytosolic Ca2+ concentration in JG cells. The endothelin system consists of 
three peptide hormones Endothelin-1, Endothelin-2 and Endothelin-3 and their G-protein 
coupled receptors ETA- and ETB-receptor. ET-1 has been determined as a strong 
vasoconstrictor in the renal vasculature mainly mediated by ETAR, whereas ETB-receptor, at 
least initially, rather promotes vasodilatation.  
Present thesis aimed to investigate either, if endothelins bind on the ETA- and/or ETB-
receptors following a Ca2+-dependent direct inhibiting effect on renin cells or if different 
systemic factors, e.g. extracellular volume, are affected by endothelins resulting in the 
modulation of the renin system in vivo. In order to characterize the role of endothelins on the 
renin system further, each single ET-receptor could be addressed as general markers for 
renin producing cells. Therefore experiments were performed with renin cell-specific ETAR or 
ETBR isoform knockout animal model (Ren1d+/Cre-ETARfl/fl, Ren1d+/Cre-ETBRfl/fl) and a renin 
cell-specific ETAR and ETBR knockout animal model (Ren1d+/Cre-ETBRfl/fl-ETARfl/fl) to assess 
a potential direct effect in vivo. Afterwards, possible indirect effects of ET-receptors based on 
vascular actions of endothelins were examined. Therefore several mouse models were 
generated additionally: ETAR and/or ETBR knockout model to study systemic effects 
(SMMHC-Cre-ERT2-ETARfl/fl,SMMHC-Cre-ERT2-ETBRfl/fl); stroma derived cell-specific effects 
(FOXD1Cre/+-ETARfl/fl, FOXD1Cre/+-ETBRfl/fl, FOXD1Cre/+- ETARfl/fl-ETBRfl/fl) and general effects in 
vivo (CAGG-Cre-ERT2-ETARfl/fl). 
All mentioned Cre+-animals, revealed normal developed renin producing cells, renin mRNA 
abundance, plasma renin concentration levels, unchanged systolic blood pressure indicating 
that each ET receptor isoform and the combination of both ET receptors located on 
mentioned cells are not of major relevance for renin synthesis and secretion. In addition, all 
Cre+ animals, except of FOXD1Cre/+- ETARfl/fl-ETBRfl/fl displayed via the isolated perfused 
kidney model an inhibition of renin secretion rate through ET-1 in increasing concentrations 
mainly mediated by a decline of the renal blood flow as in controls. Conversely all FOXD1Cre/+- 
ETARfl/fl-ETBRfl/fl animals showed no decline of renin secretion rate and an abolished decline 
of the renal blood flow indicating that these results appeared due to absence of systemic 
effects in this ex vivo situation.  
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However, present findings indicate for the very first time that ETA-and/or ETB-receptor 
isoform located on the renin cell lineage and on stroma derived cells seem to be under 
normal conditions of less relevance for the renin synthesis and secretion in vivo and in vitro 
whereas not yet addressed tubular effects or possible systemic effects are more responsible 
for inhibition of the renin system through endothelins in order to equilibrate general 
homeostasis. In addition, the role of ET-receptors located on renin producing cells in terms of 
renal pathophysiology e.g. renal fibrosis or diabetic nephropathy need to be evaluated 
prospectively further.  
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1 Introduction 
1.1 Renin-Angiotensin-Aldosterone System (RAAS) in the kidney 
The Renin-Angiotensin-Aldosterone system (RAAS) is a key regulator in homeostatic 
processes such as arterial pressure and fluid volume control in the human body.  
Since the discovery of the protease renin over 100 years ago (Tigerstedt and Bergman, 
1898), RAAS became an important target of many studies. Drugs that modulate different 
parts of this system were discovered as pharmacological tools in order to combat high blood 
pressure, myocardial infarctions and diabetic nephropathy (Cagnoni et al., 2010). Renin is a 
proteolytic enzyme which is mainly synthesized in the kidney. It has the ability to catalyze the 
hydrolysis of Angiotensinogen, a glycoprotein which is secreted from the liver into the blood, 
to Angiotensin I (ANG I) and is therefore initiator of a complex cascade of enzymes 
(Hackenthal et al., 1990; Hall, 2003; Persson et al., 2004) (see Fig.1). 
 
 
 
Fig. 1: Schematic representation of Renin-Angiotensin-Aldosterone system (explanation see text) 
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The Angiotensin-converting enzyme (ACE) is a metalloproteinase, which derives from the 
lung epithelium and transforms the biological inactive decapeptide ANG I into an octapeptide 
termed as Angiotensin II (ANG II). This biological active hormone is the main mediator of the 
system and acts via binding to angiotensin receptors which are located on cells of the 
cardiovascular, endothelial and endocrine system. ANG II acts as a vasoconstrictor and 
causes an increase in vascular resistance and by association rise of systemic blood 
pressure. In addition, ANG II stimulates the release of vasopressin in the posterior pituitary of 
the hypothalamus in order to increase water reabsorption. Furthermore, it mediates the 
intrarenal sodium and water reabsorption in the tubules via angiotensin receptors and by 
increased aldosterone synthesis in the adrenal gland (Hall, 2003; Quinn and Williams, 1988; 
Hackenthal et al., 1990). 
In humans, the activity of RAAS depends on plasma renin concentration (PRC) because the 
hydrolysis of ANG I into ANG II is limited by renin whereas Angiotensinogen and ACE are 
secreted in abundance under healthy conditions. Therefore, synthesis and secretion rate of 
renin are key targets of several negative feedback loops to regulate RAAS. It has been 
shown that increased systemic blood and renal perfusion pressure, increased tubular sodium 
concentration and also increasing amount of ANG II concentration suppresses synthesis and 
secretion of renin (Hackenthal et al., 1990; Kurtz et al., 1986b; Kurtz and Wagner, 1999; 
Vander and Geelhoed, 1965). 
1.2 Synthesis and secretion of renin in the juxtaglomerular epitheloid cell 
apparatus 
In the adult kidney, renin is synthesized in cuboid structured-like cells which are localized in 
the media layer of afferent arterioles close to the vascular pole of glomeruli (Ganten et al., 
1976; Hackenthal et al., 1990; Taugner et al., 1979; Sequeira-Lopez et al., 2015). Due to 
their almost exclusive localization cells are termed as juxtaglomerular (JG) cells (see Fig. 2). 
In humans, unlike in mice, renin is encoded by one single gene. Rodents which are used for 
scientific research can be divided into two groups. Mouse lines which possess one renin 
gene (Ren-1c) (i.e. C57/Bl6, BALB/C) and mouse lines (129 SV, Swiss) which possess two 
genes (Ren-1d and Ren-2). It is assumed that Ren-2 is established through gene duplication 
out of Ren-1 (Abel and Gross, 1990; Dickinson et al., 1984). All renin genes are encoded for 
proteins which are almost homologue on the level of amino acids but differ in glycolization 
(Sigmund and Gross, 1991). Ren-1-proteins can be glycolized to three asparagine residues 
whereas Ren-2 proteins are not known to possess binding sites for glycolization.  
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Renin is first synthesized as preprorenin with a molecular mass of 48 kDa. After 
transportation into the endoplasmatic reticulum (ER), a pre-sequence is catalyzed and given 
prorenin passes in the Golgi apparatus. There, it can enter one of two further processing 
pathways. Prorenin either can be glycolized via mannose-6-phosphate (M6P) residues, 
transported into tight, lysosomal-like dense core vesicles (DCV) and stored for regulated 
exocytosis or prorenin is not glycolized and secreted constitutively into clear vesicles. 
Glycolization is therefore prerequisite for regulated exocytosis (Morris, 1992; Mullins et al., 
2000). Therefore Ren-2 is exclusively secreted constitutively because it is free from binding 
sites for glycolization and has no function for regulated exocytosis. Only Ren-1 is stored in 
DCV (Sharp et al., 1996; Clark et al., 1997). In those vesicles the 43 amino acid long N-
terminal pro-segment of the protein is catalyzed by a proteolytic mechanism which is mainly 
unknown. Besides prorenin, several proteases such as cathepsin B (Neves et al., 1996), 
proprotein convertase PC5 (Mercure et al., 1996) and kallikrein (Kikkawa et al., 1998) are 
meant to be important mediators for processing of this pathway. The pH-value in vesicles (4-
6) is preferential for proteolysis. Active renin is stored in DCV until controlled release.  
Fig. 2: Schematic representation of glomerulus with detailed description of juxtaglomerular apparatus 
(explanation see text) modified from Dr.Karger 
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1.3 Regulation of renin synthesis and secretion 
1.3.1 Regulation through local and systemic factors 
As mentioned above, the release of active renin leads to high amount of ANG II, which is 
determining for regulation of blood pressure and sodium homeostasis. Therefore, the release 
of renin from JG cells itself is regulated by various local and systemic factors. 
1.3.1.1 Systemic blood pressure  
The concept of an intrarenal, pressure dependent mechanism which regulates the release of 
renin, was first postulated by Skinner et al. (SKINNER et al., 1964). An increase of arterial 
blood pressure leads to an inhibition of synthesis and secretion of renin via a negative 
feedback-loop. Whereas a decrease of blood pressure results into a stimulation of renin 
release (Wagner and Kurtz, 1998a). This effect has also been shown in isolated perfused 
kidneys (Scholz and Kurtz, 1993) and its most presumably a renal baroreceptor involved in 
this mechanism. This physiological key regulator is assumed to be localized in the renin 
producing cells themselves but the identification of this receptor is mostly unknown (Gomez 
and Sequeira Lopez, 2009). Isolation of JG cells causes a pressure dependent regulation of 
renin secretion. In order to stimulate an increased blood pressure, cells were mechanically 
stretched. This caused a reduced renin secretion (Ryan et al., 2000; Carey et al., 1997). The 
pathway itself is mostly unknown but it is hypothesized that a stretched cell membrane lead 
to a higher amount of calcium influx in JG cells through stretch-dependent calcium channels 
and activation of phospholipase C (Ryan et al., 2000). The absence of extracellular calcium 
prevents pressure dependent inhibition of renin secretion (Ichihara et al., 1999). The 
postulation of a calcium dependency in the baroreceptor mechanism was confirmed in 
isolated perfused mice and rat kidneys (Scholz et al., 1994a; Wagner et al., 2007). 
1.3.1.2 Salt balance 
The NaCl-balance of the human body and the salt intake which comes with daily nutrition are 
well-known regulators of RAAS activity and by association of renin synthesis and secretion. 
High concentration of oral salt intake mediates an inhibition of renin secretion and vice versa 
(Wagner and Kurtz, 1998b). Vander and Miller described present chloride concentration in 
the distal tubular structures as an important link in this mechanism (Vander and MILLER, 
1964). In addition, a cluster of specialized endothelial cells of the distal tubulus close to renin 
producing cells termed as macula densa, displays a central function in the regulation of renin 
activity. The macula densa is known to be the sensor of chloride concentration in the distal 
tubulus and therefore leads a current low ion concentration to an increase in renin secretion 
and vice versa (Skott and Briggs, 1987; Schnermann, 1998). Furthermore, specific chloride 
concentration modulates vascular resistance. More precisely, a high concentration of 
chloride concentration results in a vasoconstriction of the afferent arteriole and vice versa. 
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This effect is also termed as the tubuloglomerular feedback (Castrop, 2007; Schnermann 
and Levine, 2003). This feedback prevents loss of salt and contributes to sodium 
homoeostasis in the body. Yet, the precise mechanism remains unknown but there were 
findings which detects the apical based transporter Na+-K+-2Cl- (NKCC2) to be the sensor for 
tubular Cl--ion concentration (Lorenz et al., 1991; Bell and Lapointe, 1997). The macula 
densa cells release ATP when a high Cl--concentration is present and can therefore 
modulate renin secretion. In contrast, a low ion concentration leads to an increase release of 
prostaglandin E2 (PGE2) via COX-2 and nitric oxide (NO) via neuronal NO-synthases 
(nNOS) (Bell et al., 2003; Kurtz and Wagner, 1998; Peti-Peterdi et al., 2003; Yang et al., 
2000). PGE2 and NO are also known to stimulate renin secretion for a short-term basis but 
recent studies identifies, both not essential for salt-dependent regulation of renin secretion 
(Sallstrom et al., 2008; Kim et al., 2007; Castrop et al., 2004; Hoecherl et al., 2002). In 
conclusion, the macula densa mechanism as mentioned above is important for detecting 
spontaneous alterations of tubular Cl- concentration associated by modulation of renin 
secretion. However it still remains unknown if the macula densa cells or which factors do play 
a key role in the long-term mechanism of salt-dependent regulation of renin secretion.    
1.3.1.3 Sympathetic nervous system  
The tubular system, the renal vascular system and the juxtaglomerular apparatus are 
innervated by the sympathetic nervous system (Hackenthal et al., 1990). Boivin et al. could 
localize the β1 adrenoreceptor on JG cells (Boivin et al., 2001), which leads to an increase in 
cAMP production in JG cells when activated through renal nervous system. A higher amount 
of cAMP production is known to stimulate renin secretion (DiBona and Kopp, 1997). In 
addition, a vasoconstrictive effect of afferent arterioles via activation of α adrenoreceptors 
triggers secretion of renin (Ehmke et al., 1989; Kirchheim et al., 1985). But sympathetic input 
of local nerve endings is not essential for modulation of renin secretion while reacting on 
various stimuli. Renin secretion was altered even at complete renal denervation as well as at 
pharmacological inhibition of β adrenoreceptors (Golin et al., 2001; Holmer et al., 1994; 
Holmer et al., 1993). Therefore, β1 adrenoreceptors seem to be essential for providing renin 
synthesis rate, which allows an availability of ready-to-use renin vesicles. This high amount 
of renin vesicles enables the reaction of external stimuli.  
1.3.1.4 Angiotensin II 
Angiotensin II is the effector hormone in the RAAS and mediates its physiological function 
mainly via angiotensin type-1 receptors (AT1 receptors). When circulating in the 
bloodstream, ANG II inhibits renin synthesis and secretion via negative feedback loop 
(Hackenthal et al., 1990; Muller et al., 2002). Experiments display an increase in renin 
synthesis and rate, after inhibiting or blocking AT1 receptor (Castrop et al., 2003; Hoecherl et 
al., 2001) whereas exogenic infusion of ANG II in rats and mice lowers them (Schunkert et 
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al., 1992). The effect of ANG II on the renin secretion is independent of renal perfusion 
pressure or salt concentration in tubular cells leading to hypothesis of a direct effect on the 
level of renin producing cells. In addition, the expression of AT1 receptors on renin producing 
cells supports this theory (Harrison-Bernard et al., 1997; Kimura et al., 1997). ANG II 
mediates an increase of intracellular concentration of calcium which inhibits the release of 
renin. However, recent experiments could negate the theory of a direct effect. A renin cell-
specific AT1a receptor animal model was generated where no difference either in renin 
mRNA abundance or in plasma renin concentration could be obtained compared to control 
littermates (unpublished data). 
In addition, ANG II is a vasoconstrictor and inhibits renin secretion indirectly through 
enhanced blood pressure where it promotes aldosterone and adrenaline release in the 
adrenal gland and triggers sensation of thirst via stimulation of AT1 receptors in the 
hypothalamus (Hackenthal et al., 1990; Crowley et al., 2005). 
1.3.1.5 Controlling of renin release on cellular level 
The systemic and local factors mentioned above which modulate renin secretion and 
synthesis all result in three main intracellular second messenger systems with following 
signaling molecules: cyclic nucleotides cAMP and cGMP and the intracellular free calcium 
concentration (Schweda and Kurtz, 2004; Castrop et al., 2010; Grünberger et al., 2006).  
Due to a variety of indirect and direct evidences, cAMP is postulated as the central 
intracellular stimulator of renin release. An increase in cAMP stimulates protein kinase A 
(PKA) which induces renin exocytosis. All mentioned extracellular stimulating factors mediate 
Fig. 3: Intracellular signaling pathways controlling renin exocytosis (Castrop et al., 2010) 
(explanation see text) 
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their effect by stimulating intracellular cAMP concentration. The amount of cAMP 
concentration is triggered by either receptor induced activation of adenylyl cyclase or 
inhibition of cAMP phosphodiesterase (PDE). 
Pharmacological stimulation of β adrenoreceptors stimulates cAMP concentration via 
activation of adenylyl cyclase which in turn increases renin secretion (Keeton and Campbell, 
1980; Vandongen et al., 1973; Weinberger et al., 1975). In addition, the direct activation of 
adenylyl cyclase activity by forskolin, a labdane diterpene, increases cAMP levels and renin 
release in JG cells (Castrop, 2007; Kurtz et al., 1984; Grünberger et al., 2006). For cAMP 
production in renin juxtaglomerular cells one of the main adenylyl cyclases isoforms are AC-5 
and AC-6 (Grünberger et al., 2006; Ortiz-Capisano et al., 2007b, 2007c). 
As mentioned above, intracellular cAMP levels are also determined by cAMP hydrolysis to 5‘-
AMP through the activity of cAMP PDEs. A nonselective inhibition of PDE activity using 3-
isobutyl-1-methylxanthine (IBMX) stimulates renin release. Studies with selective blockers of 
PDE-1,-3 and -4 isoforms displayed similar results (Chiu et al., 1996; Chiu and Reid, 1996; 
Chiu et al., 1999; Castrop, 2007) (see Fig.3). 
Although, a variety of studies could indicate that cAMP is the main stimulator of renin 
release, the complete mechanisms how cAMP mediate renin exocytosis remains unknown. 
The release of renin by cAMP involves a PKA-dependent step, but phosphorylation targets of 
PKA in JG cells are still unknown (Friis et al., 2002; Castrop, 2007; Kurtz et al., 1998b).  
In contrary to cAMP, the effects of cGMP are able to either stimulate or inhibit renin secretion 
in JG cells. Low cGMP concentration in those cells seems to stimulate renin secretion 
whereas high concentration rather mediates an inhibiting effect. Whereas stimulating and 
inhibiting cGMP signaling pathways seem to be localized in different parts of the cell.   
It has been shown that decreased concentration of cGMP mediates an inhibiting effect on 
PDE-3 synthesis which leads to an increased cAMP concentration and a strong renin 
exocytosis (Kurtz et al., 1998b; Kurtz and Wagner, 1998; Beierwaltes, 2006). This so called 
cAMP-cGMP interaction was confirmed in both patch-clamp experiments on single JG cells 
and in vivo (Friis et al., 2002; Beierwaltes, 2006). Additionally, cGMP-inhibited PDE-3 plays a 
mediator role in the stimulation of renin release by nitric oxide (NO). The activated soluble 
guanylate cyclase (sGC) which is activated by NO as well as PDE-3 is localized in the 
cytosol. Therefore, cGMP produced by sGC inhibits PDE-3 which could explain the 
stimulating effect of NO on renin secretion (Kurtz et al., 1988; Kurtz et al., 1998a). In contrast 
to sGC, the membrane-bound particulate guanylate cyclase (pGC) is located next to vesicles 
which are associated with cGMP-dependent proteinkinase II (cGKII) and it has been shown 
to be activated by atrial natriuretic peptide (ANP). ANP is known to inhibit renin exocytosis, 
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which could be explained by produced cGMP from pGC which in turn inhibits cGKII and by 
implication renin release (Vandongen et al., 1973; Kurtz et al., 1986a; Wagner and Kurtz, 
1998b) (see Fig.3). 
In contrast to cAMP and cGMP signaling control on renin release, free cytosolic Ca2+ 
concentration is considered as the primary inhibitor (Castrop et al., 2010). Therefore, an 
increased intracellular Ca2+ concentration in JG cells mediates an inhibition of renin secretion 
and a low concentration enhances renin secretion out of the vesicles. But in all other 
secretory cells, except parathyroid gland cells, an increased cytosolic Ca2+ concentration 
initiates and supports renin exocytosis (Cohen et al., 1997). This phenomenon in JG cells 
has been termed as the “calcium paradoxon” of renin release. Many hormones, for example, 
ANG II and arginine vasopressin are suggested to mediate their inhibiting effect in JG cells 
via an increase of cytosolic Ca2+ concentration (Ichihara et al., 1995; Kurtz et al., 1986b; van 
Dongen and Peart, 1974). Further, the usage of BAPTA, an intracellular Ca2+ chelator, 
reduces cytosolic Ca2+ concentration and stimulates renin secretion (Ortiz-Capisano et al., 
2007a; Ortiz-Capisano et al., 2007c).  
Not only intracellular Ca2+ concentration, but also extracellular concentration of Ca2+ is known 
to modulate renin secretion. Several studies on isolated JG cells, glomeruli, kidneys and also 
on single kidney sections demonstrated an increased renin secretion after reducing 
extracellular Ca2+ concentration (Moe et al., 1991; Scholz et al., 1994b; Baumbach et al., 
1976; Ortiz-Capisano et al., 2007c; Kurtz and Wagner, 1999). Presumably, low extracellular 
Ca2+ -concentration turns into low transmembrane Ca2+ influx which results in menial amount 
of Ca2+ ions in the cytosolic area. In addition, these parallel changes in the extra- and 
intracellular Ca2+ concentrations, the Ca2+-sensing receptor, which also controls the release 
of the parathyroid hormone in a Ca2+-dependent manner, may participate in the regulation of 
renin release by the extracellular ion concentration (Ortiz-Capisano et al., 2007a; Kurtz and 
Wagner, 1999; Castrop et al., 2010). 
However, the specific mechanisms behind the suppression of renin release in response to an 
increasing concentration of cytosolic Ca2+ remain unknown and need to be investigated 
further. Recent studies focused on a further downstream target of Ca2+, specifically, the Ca2+-
inhibited adenylyl cyclases AC5 and AC6 (Kurtz and Penner, 1989; Hackenthal et al., 1990; 
Castrop et al., 2010; Schweda and Kurtz, 2004; Grünberger et al., 2006; Ortiz-Capisano et 
al., 2007c). High Ca2+ concentration inhibits both cyclases which turns into decreased cAMP 
concentration and suppression of renin secretion (Ortiz-Capisano et al., 2007c; Grünberger 
et al., 2006).  
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Further, evidences suggest that the suppression of renin release by Ca2+ involves 
Ca2+/calmodulin-dependent processes or activation of proteinkinase C (Castrop, 2007; 
Hackenthal et al., 1990; Kurtz and Wagner, 1999; Schweda and Kurtz, 2004).  
1.3.2 Endothelins as potential regulators of RAAS 
A variety of in vitro studies and one in vivo study using dogs have examined endothelins 
(ETs) as negative regulators of renin synthesis and secretion out of the cell, mediating their 
direct effect through an increase in cytosolic Ca2+ concentration (Berthold et al., 1999; Scholz 
et al., 1995; Ritthaler et al., 1995; Ritthaler et al., 1996). However it still remains unknown to 
what extend the inhibiting direct effect becomes relevant in vivo. 
1.3.2.1 General characterization of the endothelin system 
In 1988, a 21-amino acid vasoconstricting factor termed endothelin was isolated from 
cultured porcine aortic endothelial cells (Yanagisawa et al., 1988). ETs are a family of 
naturally occurring peptides with well-established growth-promoting, vasoactive and 
nociceptive properties that affect the function of a number of tissues and systems. The 
endothelin system consists of endothelin-1 (ET-1), endothelin-2 (ET-2) and endothelin-3 (ET-
3). 
ET-1 is a 21-amino-acid peptide with a hydrophobic C-terminus and two cysteine bridges at 
the N-terminus. In addition, two structurally related peptides differing by two and six amino 
acids were identified and termed as ET-2 and ET-3 shortly after (Yanagisawa and Masaki, 
1989). In humans, endothelin represents the most potent and long-lasting vasoconstrictor 
known, being 100 times more potent than noradrenaline (Yanagisawa et al., 1988; Luscher 
furin-like protease
preproET-1 preproET-2 preproET-3
big ET-1 big ET-2 big ET-3
ET-1 ET-2 ET-3
furin-like protease furin-like protease
ETA receptor ETB receptor
Gq, Gs, … Gq, Gi, …
ECE-1,ECE-2 ECE-1,ECE-2 ECE-1,ECE-2
Fig. 4: Schematic representation of the endothelin pathway (adapted from Kedzierski and 
Yanagisawa, 2001) preproET: preproendothelins; ECEs: endothelin-converting enzymes; Gx: various G 
proteins 
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and Barton, 2000; Maguire and Davenport, 2002; Hillier et al., 2001; Davenport et al., 2016). 
ET-1 is suggested as the predominant isoform and the biologically most relevant (Luscher 
and Barton, 2000; Kedzierski and Yanagisawa, 2001) and is produced by smooth muscle 
cells, vascular endothelial cells, macrophages, fibroblasts and brain neurons among others 
(Ortmann et al., 2005; Luscher and Barton, 2000; Kedzierski and Yanagisawa, 2001). ET-2 
expression is found in the ovary and in intestinal epithelial cells such as in lung 
alveolarization. ET-3 can be determined in endothelial cells, brain neurons, and renal tubular 
epithelial cells rather mediating the release of vasodilators, including NO and prostacyclin 
(Kedzierski and Yanagisawa, 2001). In the kidney, ET-1 is synthesized by endothelial cells of 
vessels and ET-1 such as ET-3 are exclusively expressed in epithelial cells of medullary and 
cortical collecting ducts (Kohan, 1991; Karet and Davenport, 1996). 
The endothelin precursors are processed by two proteases to create the mature active form. 
The so called preproendothelins are cleaved at dibasic sites via furin-like proteases and form 
physiological inactive 37-41-amino acid long peptides termed big endothelins. Big ETs are 
cutted via endothelin-converting enzymes (ECEs) at the Trp-Val of ET-1 and ET-2 at the Trp-
Ile of ET-3 to build the final peptides (Inoue et al., 1989; Kedzierski and Yanagisawa, 2001).  
In mammals, all three peptides mediate their actions via two 7-transmembrane domain, G-
protein coupled receptors. They have been identified and termed as Endothelin-A and 
Endothelin-B (ETAR,ETBR) receptor (Masaki et al., 1994; Davenport, 2002; Arai et al., 1990; 
Sakurai et al., 1990). Whereas ETAR has been determined to display similar affinities for ET-
1 and ET-2 signaling and 100-fold lower affinity for ET-3 (Barton and Yanagisawa, 2008; 
Kedzierski and Yanagisawa, 2001). ETBR receptor shows equal affinities for all ETs (Barton 
and Yanagisawa, 2008). (see Fig.4) 
1.3.2.2 Role of endothelin system in the kidney 
In the kidney, all ETs have been shown to equipotently inhibit cAMP-stimulated renin 
secretion in a Ca2+-dependent fashion from cultured renal JG cells in vitro  but it still remains 
unknown wether ETAR and/or ETBR is involved in this mechanism (Ritthaler et al., 1995; 
Ritthaler et al., 1996) and if the effects are reproducible in vivo. ETAR and ETBR are widely 
distributed in the kidney whereas one single cell can express one or both receptor isoforms 
(Kohan et al., 2011a). In general, ETAR has been shown to be localized in vascular smooth 
muscle, mesangial cells, pericytes, collecting duct and thick ascending limb, while ETBR 
predominates on endothelial cells and renal tubules (Kohan et al., 2011a). ET receptors 
activate a host of signaling systems that vary on the cell type and mediate therefore often 
different biological effects (Kohan, 2010). ET receptors connect to different members of the 
G protein family (see Fig. 4) where actions result in a variety of signaling cascades, including 
adenylyl cyclases, cyclooxygenases (COX), nitric oxide synthase (NOS) and others (Kohan 
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et al., 2011b). The ETAR receptor has been considered as the primary vasoconstrictor and 
growth promoter whereas ETBR rather has been suggested, at least initially, to cause 
vasodilatation and inhibit cell growth (Kohan et al., 2011a; Kohan, 2010; Kohan et al., 2011b; 
Barton and Yanagisawa, 2008; Yanagisawa et al., 1988). In addition, various studies 
hypothesized endothelins as regulators of several aspects of kidney physiology since ET-1 
could be determined to be synthesized in almost every cell type within the organ (Kohan et 
al., 2011b). Further, ETAR and ETBR could be localized in kidney tissue, as mentioned 
above, in abundance, the endothelin system has been postulated to be a potential regulator 
of renal blood flow, glomerular filtration rate and transport of sodium, water, protons and 
bicarbonate (Kohan et al., 2011a). Administration of ET-1 in anesthetized rabbits reduced 
cortical perfusion, urinary flow, sodium excretion, cortical perfusion and glomerular filtration 
rate (Evans et al., 1998). Further, ET system has emerged as being of importance in 
mediating renal injury and/or disease progression in a variety of pathological conditions 
including hypertension, ischemia, congestive heart failure, stroke, diabetic retinopathy and 
nephropathy as acute and chronic renal failure (Rubanyi and Polokoff, 1994; Kohan, 2010). 
ETs derived from individual renal cells act primarily in an autocrine or paracrine fashion; thus 
the renal ET system must be viewed within the context of the local microenvironment. 
Several studies administered key ET agonists and antagonists to get a closer focus on the 
role of renal ET in the regulation of blood pressure and sodium homeostasis (Maguire and 
Davenport, 2015). The cyclic pentapeptide BQ-123 (D-Asp-L-Pro-D-Val-Leu-D-Trp-) and a 
linear tripeptide termed as FR139317 (N-[N-[N-[(Hexahydro-1H-azepin-1-yl)carbonyl]-L-
leucyl]-1-methyl-D-tryptophyl]-3-(2-pyridinyl)-D-alanine) are well-known highly selective ETA-
receptor antagonists in mammals which have been used in Research and Clinical Studies 
(Ihara et al., 1992; Aramori et al., 1993; Maguire and Davenport, 2015). Thereby, ET-1 was 
shown to mediate renal vasoconstriction most presumably via ETA receptor signaling 
pathway, although it is not apparent from the studies, if ETA-receptor antagonists are able to 
prevent ET-1 induced vasoconstriction (Schmetterer et al., 1998). Still, medical studies 
examined that BQ123 inhibited the ET-1 mediated increase in renal vascular resistance of 
human patients promoting further ETAR as being the main vasoconstrictor (Kaasjager et al., 
1997; Bohm et al., 2003). The usage of BQ788, a highly selective ETBR antagonist, supports 
hypothesis of ET-1 actions in renal vascular system (Bohm et al., 2003; Maguire and 
Davenport, 2015). In addition, the ET receptor subtype B has been shown to rather play an 
important role in the clearance of exogenous ET-1, which could be shown in administration of 
BQ788 in endothelial cell-specific knockout rats (Kelland et al., 2010; Fukuroda et al., 1994).  
In summary, endothelin is an important proven inhibiting factor of the renin system in vitro 
and has emerged as a crucial regulator in a variety of renal pathologies (Kedzierski and 
Yanagisawa, 2001; Davenport et al., 2016; Palmer, 2009; Patel and McKeage, 2014; 
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Sidharta et al., 2015). Regarding the renin system, endothelin is thought to exert its effect 
through vasoconstriction in the renal vascular system and/or a potential direct inhibitory 
effect on renin producing JG cells. Among the two present ET receptor subtypes, it remains 
unknown if ETAR and/or ETBR are localized on renin producing JG cells and if the inhibiting 
effect of endothelins on renin synthesis and secretion is a direct effect on the level of those 
cells in vivo. 
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1.4. Aim of thesis 
The protease renin is considered as a central regulatory factor of the renin-angiotensin-
aldosterone system. It is synthesized primarily from juxtaglomerular epitheloid cells in the 
kidney and stored until release in secretory vesicles. Exocytosis and synthesis of renin from 
JG cells itself is regulated by different systemic and local factors.  
Synthesis and secretion of renin is stimulated through cAMP signaling pathway and is, while 
focusing on local factors, primarily inhibited by an increase cytosolic concentration of Ca2+ in 
JG cells. A large number of vasoconstrictor hormones such as ANG II and arginine 
vasopressin have been shown to inhibit renin release from juxtaglomerular epithelial cells in 
the kidney.  
In addition, endothelins have been suggested as negative regulators of renin secretion and 
synthesis. The endothelin system consists of three peptide hormones Endothelin-1, 
Endothelin-2 and Endothelin-3 and their G-protein coupled receptors ETA- and ETB-
receptor. ET-1 has been determined as a strong vasoconstrictor in the renal vascular system 
mainly mediated by ETAR, whereas ETB-receptor rather promotes vasodilatation. 
Concerning the contribution of endothelins on the regulation of the inhibition of renin 
exocytosis and synthesis, it still remains unknown either if endothelins bind on their receptors 
following a Ca2+-dependent direct inhibiting effect on renin cells or if different systemic 
factors, e.g. extracellular volume, are affected by endothelins resulting in modulating RAAS. 
Endothelins can modify blood pressure through their vasoconstrictive and vasodilatory 
characteristic or through effects located on the tubular system which regulates for example 
the extracellular volume.  
Previous in vitro studies have shown that endothelins, focusing on ET-1 inhibit the renin 
synthesis and secretion (Ritthaler et al., 1995; Ritthaler et al., 1996; Berthold et al., 1999; 
Scholz et al., 1995; Ackermann et al., 1995) The work at hand concentrates on in vivo 
investigations which mechanisms mentioned above play a central role and moreover which 
ET-receptors are relevant.  
In order to characterize the role of endothelins on the renin system, the first part of present 
thesis, focusses on the localization of each ET-receptor isoform in the adult murine kidney. 
With the help of immunohistochemistry and in situ hybridization assay both ET-receptors 
were determined in different localization sites of the kidney.  
The second part of this study concentrates on the relevance of renal ETA-receptor isoform 
as well as ETBR receptor isoform for renin synthesis and secretion in vivo and in vitro. 
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In the beginning, it was ineluctable to investigate a potential direct effect on the level of renin 
producing cells. Therefore, the generation of a renin cell-specific ETAR as well as an ETBR 
knockout model was necessary (Ren1d+/Cre-ETARfl/fl, Ren1d+/Cre-ETBRfl/fl).  
Afterwards, possible indirect effects of ET-receptor isoforms based on vascular actions of 
endothelins were examined. Thereby the generation of additional cell-specific animal models 
of single ET-receptors were provided: α-sma-ETAR or ETBR knockout model to study 
systemic effects on the renin system (SMMHC-Cre-ERT2-ETARfl/fl, SMMHC-Cre-ERT2-
ETBRfl/fl); a stroma derived ETAR or ETBR knockout model in order to study if ET-receptors 
located on stroma derived cells are involved in the renin synthesis and secretion (FOXD1Cre/+-
ETARfl/fl, FOXD1Cre/+-ETBRfl/fl) and a conditional ETAR knockout model (CAGG-Cre-ERT2-
ETARfl/fl) to investigate if general ETAR expression is relevant for the regulation of the 
inhibition of renin synthesis and secretion. 
In the last few years, theories of potential ET-receptor interactions have been discussed. 
Therefore, third part of present thesis focusses on the importance of both renal ET-receptors 
for the renin synthesis and secretion in vivo and in vitro. To investigate if both ET-receptors 
mediate the renin system through a direct effect in vivo and in vitro, a renin cell-specific ET-
receptor “double-knockout” model (Ren1d+/Cre-ETARfl/fl-ETBRfl/fl) was used for further 
experiments. In addition, to answer the question if both ET-receptors located on stroma 
derived cells are relevant for the regulation of the renin system, a stroma derived ET-
receptors “double knockout” animal model was provided (FOXD1Cre/+-ETARfl/fl-ETBRfl/fl). 
Altogether, by means of different parts of investigations this work contributes to research on 
possible factors which modulate renin synthesis and secretion out of secretory vesicles, 
concentrating on negative regulators of renin release. The ET system, primarily ET-1 has 
been shown to inhibit renin release in vitro whereas the characterization if this inhibition is 
controlled by a possible direct effect on renin producing cells or a potential indirect effect 
through ET-1/ETA and/or ETBR has yet to be resolved and has been considered as one of 
the main approaches of present thesis.  
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2 Material and Methods 
2.1 Material 
2.1.1 Appliances 
APPLIANCE COMPANY 
agarose gel 
electrophoresis Compact M, Biometra, Göttingen 
autoclave DX-23, Systec, Linden 
blood pressure 
measuring monitor 
blood pressure measuring Monitor, 9001-series; TSE 
Systems, Bad Homburg 
camera 
AxioCam MRm, Zeiss, Jena 
Axiocam 105 color, Zeiss, Jena 
centrifuges 
Labofuge 400, Heraeus, Hanau 
centrifuge 5415C, Eppendorf, Hamburg 
computer Precision 690, Dell, Frankfurt am Main 
cryostat CM 3050S, Leica, Wetzlar 
filter sets 
TRITC-Filter: 
excitation 533-558 nm 
emission 570-640 nm 
Cy2-Filter: 
excitation 450-490 nm 
emission 500-550 nm 
 
filter set 43 DsRed, Zeiss, Jena 
 
 
filter set 38 HE, Zeiss, Jena 
 
 
Material and Methods 
21 
 
Cy5-Filter: 
excitation  625-655 nm 
emission 665-715 nm 
DAPI-Filter: 
excitation  335-383 nm 
emission 420-470 nm 
filter set 50, Zeiss, Jena 
 
 
filter set 49, Zeiss, Jena 
fluorescent lamp Colibri.2, Zeiss 
heat block 
Thermomixer, Eppendorf, Hamburg 
Thermomixer 5436, Eppendorf, Hamburg 
heat chamber Memmert, Schwabach 
heat plate HI 1220, Leica, Wetzlar 
heating bath 
Modell W13, Haake, Karlsruhe 
1083, GFL, Burgwedel 
homogenizer Ultra-Turrax T25, Janke & Kunkel, Staufen 
ice machine Ziegra Eismaschinen, Isernhagen 
incubator 
Model B6200, Heraeus, Hanau 
Modell 300, Memmert, Schwabach 
magnetic mixer 
MR 80, Heidolph, Schwabach 
MR 3001 K, Heidolph, Schwabach 
microscope Axio Observer Z1, Zeiss, Jena 
microtome rotary microtome RM2165, Leica, Wetzlar 
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microwave Sharp, Osaka 
PCR-cycler 
Labcycler, Sensoquest, Göttingen 
Lightcycler LC480, Roche, Mannheim 
perfusion pump 323, Watson Marlow, Wilmington, USA 
pH electrode Hanna Instruments, Vöhringen 
photometer NanoDrop 1000, Peqlab, Erlangen 
pipettes 
Pipetman P10, P20, P100, P200, P1000, 
Gilson, Middleton, USA 
pure water system MilliQ Plus PF, Millipore, Schwalbach 
refrigerator/freezer 
Santo refrigerator, AEG, Nürnberg 
Comfortplus freezer, Liebherr, Ochsenhausen 
Ultra-low-freezer -85°C, New Brunswick Scientific 
RNAscope® heat oven 
HybEZ Oven, Advanced Cell Diagnostics (ACD), 
Hayward, USA 
scales 
Scale ABT 120-5DM, kern, Balingen-Frommern 
EMS, Kern, Balingen-Frommern 
scan table Marzhäuser Sensotech GmbH, WTzlar 
shaker 
GFL, Burgwedel 
Rotamax, Heidolph, Schwabach 
UV dark chamber Fusion FX7, Vilber, Eberhardzell 
UV light table fluorescent tables, Renner, Dannstadt 
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2.1.2 Consumable material 
vortex mixer USA REAX1, Heidolph, Schwabach 
water bath 
Aqualine, AL12, Lauda, Lauda-Königshofen 
1083, GFL, Burgwedel 
PRODUCT COMPANY 
cover slips Roth, Karlsruhe 
dissecting set Hammacher, Solingen 
falcon 15 ml, 50 ml Sarstedt, Nümbrecht 
filter Schleicher & Schuell, Dassel 
glassware 
Roth, Karlsruhe 
Schott, Mainz 
gloves neoLab Migge GmbH, Heidelberg 
hematocrit capillaries Sanguis Counting, Nürnbrecht 
hematocrit sealing kit Brand, Wertheim 
light cycler multiwell plates 96 Sarstedt, Nürnbrecht 
liquid blocker pen 
Super PAP-Pen, Science Services, 
Munich 
ImmEdge Pen, Vector Laboratories, 
Burlingame, USA 
low salt chow 0.02 % NaCl 
high salt chow, 5 % NaCl 
Ssniff, Soest 
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2.1.3 Chemicals, Enzymes, Kits 
microscope slides, Superfrost Plus Menzel-Gläser, Braunschweig 
mold (silicone rubber) Roth, Karlsruhe 
needles Becton Dickinson, Franklin Lakes, USA 
paraffin wax Sarstedt, Nümbrecht 
parafilm Bemis, Neenah, USA 
pasteur pipettes VWR, Darmstadt 
pipette tip (filter or no filter) 
Sarstedt, Nümbrecht 
Biozym Scientific, Hessisch Oldendorf 
neoLab Migge GmbH, Heidelberg 
serological 5 ml, 10 ml, 25 ml 
pipettes 
Sarstedt, Nürnbrecht 
surgical blade Feather, Köln 
tissue embedding cassettes Roth, Karlsruhe 
tubes, 0.5 ml, 1.5 ml, 2.0 ml Sarstedt, Nümbrecht 
PRODUCT COMPANY 
agarose Biozym, Oldendorf 
ammonium hydroxide solution Sigma-Aldrich, Munich 
bovine serum albumin (BSA) Sigma-Aldrich, Munich 
Dulbecco’s PBS Sigma-Aldrich, Munich 
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chloroform Merck, Darmstadt 
diethyl pyrocarbonate (DEPC) Fluka, Neu-Ulm 
DNA ladder: gene ruler 
Gene Ruler™ 100bp plus DNA ladder, 
Thermo Scientific, Waltham, USA 
ELISA-kit (ANG I) PRA IBL International, Hamburg 
enalapril Sigma, Deisenhofen 
ethanol p.a. Honeywell, Morris Plains, USA 
Ethylendiamintetraacetate (EDTA) Merck, Darmstadt 
formaldehyde solution (37 %) Merck, Damrstadt 
glycergel Mounting Medium (IHC) Dako Cytomation, Glostrup, Dänemark 
glycerol 87 % AppliChem, Darmstadt 
goTaq DNA Polymerase, 5 U/μl Promega, Mannheim 
GoTaq Reaction Buffer Green, 5x bzw. 
Colorless, 5x 
Promega, Mannheim 
HCl 1N Merck, Darmstadt 
hematoxylin Gill Nr.1, Sigma Aldrich, Munich 
heparin Liquemin® 25000 (5000 I.E./ml) Roche, Mannheim 
horse serum 
Gibco, Life technologies, Grand Island, 
USA 
isopropyl alcohol Merck, Darmstadt 
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isopropyl alcohol (p.a.) AnalaR Normapur, VWR, Radnor, USA 
isotonic NaCl solution 0.9 % B. Braun, Melsungen 
K2HPO4 x 3 H2O Merck, Darmstadt 
KCl Merck, Darmstadt 
ketamine 10 % Bela-pharm, Vechta 
KH2PO4 Merck, Darmstadt 
methanol Merck, Darmstadt 
MgCl2 Merck, Darmstadt 
M-MLV reverse transcriptase, 200 u/µl Invitrogen, Karlsruhe 
Na2HPO4 Sigma-Aldrich, Munich 
Na2HPO4 x 2 H2O Merck, Darmstadt 
NaCl Merck, Darmstadt 
NaH2PO4 Sigma-Aldrich, Munich 
NaOH 1N Merck, Darmstadt 
nonfat dry milk Biorad, Munich 
nuclease-free water GibcoBRL, Eggenstein 
Oligo(dT)15 Primer, 0.5 μg/μl Thermo Scientifix, Waltham, USA 
paraformaldehyde Roth, Karlsruhe 
Paraplast-Plus paraffin Sherwood, St. Louis, USA 
PCR nucleotide mix Promega, Mannheim 
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2.1.4 Buffer and solutions 
So far as not mentioned further, chemicals for buffer and solutions were dissolved in 
H2Obidest..  
 
(dATP, dCTP, dGTP, dTTP, je 10 mM) 
RNAscope® 2.5 HD detection reagents ACD, Hayward, USA 
RNAscope® H2O2 & protease plus 
reagents 
ACD, Hayward, USA 
RNAscope® Target retrieval reagents ACD, Hayward, USA 
RNAscope® washing buffer ACD, Hayward, USA 
Roti®-safe gel stain Roth, Karlsruhe 
SYBR® Green PCR Kit Roche, Mannheim 
tamoxifen chow (400 mg tamoxifen 
citrate/kg) 
Harlan Laboratories, NM Horst, 
Niederlande 
Tissue-TeK® Sakura, NL 
Tris(hydroxymethyl)aminomethane 
(TRIS) 
Affymetrix, Cleveland, USA 
PeqGold TriFast™ Peqlab, Erlangen 
VectaMount™ Vector, Laboratories 
xylazine, 2 % Serumwerk, bernburg 
xylol 
xylol (p.a) for ISH 
Merck, Darmstadt 
AppliChem, Darmstadt 
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2.1.4.1 Immunohistochemistry and in situ hybridization 
 
Fixation for perfusion (IHC), pH 7,4 
 PBS (Phosphate Buffered Saline) buffer Dulbecco 
 Paraformaldeyde     3 % 
Fixation for perfusion (RNAscope®/BASEscope® ISH) pH 7 
 Formaldehyde solution    25 ml 
 Na2HPO4      1.625 g/l 
 NaH2PO4      1 g/l 
 H2O Millipore      225 ml 
PBS-(Phosphate Buffered Saline) Buffer 
 NaCl       136 mM 
 KCl       2.7 mM 
 Na2HPO4 x 2H2O     10.1 mM 
 KH2PO4      1.8 mM 
PBS-Otto-Buffer, pH 7,4 
 K2HPO4 x 3H2O     10 mM 
 NaCl       140 mM 
 KH2PO4      10 mM 
Blocking solution A 
 dry milk powder     5 % 
 PBS buffer 
Blocking solution B 
 BSA (Bovine Serum Albumin)   1 % 
 HS (Horse Serum)     10 % 
 PBS buffer 
2.1.4.2 Molecular biology 
 
Agarose gel 
TAE 
agarose       2 % 
Roti®-gel stain 
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DEPC-H2O 
1/1000 Vol. DEPC diluted in ddH20, agitate, 
leave open under hood overnight, autoclave afterwards 
 
NaOH for gDNA-Extraction 
 
NaOH       25mM 
 
10x TAE (Tris-acetic-EDTA), pH 8,5 
 
Tris        40 M 
Acetic acid      20 M 
EDTA        1 M 
 
 
Tris HCl for gDNA-Extraction, pH8,0 
 
Tris HCl       1 M, pH 8 
 
2.1.5 Oligonucleotides 
Oligonucleotide-Primer were synthesized and sent in a lyophilized manner by Eurofins 
MWG®. After adding nuclease-free water a concentration of 100 pmol/µl was calculated.  
 
name species orientation sequence from 5‘ to 3‘ 
genotyping 
ETAR mus musculus 
fw 
CCT CAG GAA GGA AGT 
AGC AAG 
rev 
ACA CAA CCA TGG TGT 
CGA 
 
ETBR 
WT 
 
mus musculus 
fw 
CTG AGG AGA GCC TGA 
TTG TGC CAC 
rev 
CGA CTC CAA GAA GCA 
ACA GCT CG 
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ETBR KO mus musculus 
fw 
TGG AAT GTG TGC GAG 
GCC 
rev 
CAG CCA GAA CCA CAG 
AGA CCA CCC 
RenCre mus musculus 
653 Ren1d 
GAA GGA GAG CAA AAG 
GTA AGA G 
468 Ren1d 
GTA GTA GAA GGG GGA 
GTT GTG 
400 Cre 
TTG GTG TAC GGT CAG TAA 
ATT GGA C 
SMMHC-
Cre-ERT2 
mus musculus 
SMWT1 
TGA CCC CAT CTC TTC ACT 
CC 
SMWT2 
AAC TCC ACG ACC ACC 
TCA TC 
phCREAS1 
AGT CCC TCA CAT CCT CAG 
GTT 
FoxD1-
Cre 
mus musculus 
FOXD1-Cre s 
TCT GGT CCA AGA ATC 
CGA AG 
FOXD1-Cre as 
GGG AGG ATT GGG AAG 
ACA AT 
FOX-D1-Cre WT s 
CTC CTC CGT GTC CTC 
GTC 
CAGG-
Cre-ERT2 
mus musculus 
mCAGG s geno 
CTC TAG AGC CTC TGC TAA 
CC 
mCAGG as geno 
CGC CGC ATA ACC AGT 
GAA AC 
mRNA-studies 
GAPDH mus musculus 
GAPDH fw 
ATG CCA TCA CTG CCA 
CCC AGA AG 
GAPDH rev ACT TGG CAG GTT TCT CCA 
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GGC 
renin mus musculus 
Renin fw 
ATG AAG GGG GTG TCT 
GTG GGG TC 
Renin rev 
ATG CGG GGA GGG TGG 
GCA CCT G 
ETAR mus musculus 
fw 
AGG AAC GGC AGC TTG 
CGG AT 
rev 
AGC AAC AGA GGC AGG 
ACT GA 
ETBR mus musculus 
fw 
GAA GAG CGG TAT GCA 
GAT TG 
rev 
TAT TGC TGG ACC GGA 
AGT TG 
Table 1: Oligonucleotide sequence for PCR and quantitative real-time RT-PCR; fw = forward, rev = 
reverse; 
2.1.6 Antibodies and hybridization probes (ISH) 
 
first 
antibody 
clonality company dilution 
chicken anti-
renin-IgG 
polyclonal 
Davids Biotech, 
Regensburg 
1:400 
mouse-anti-
smooth-muscle 
actin-IgG 
polyclonal Abcam, Cambridge, 
UK 
1:400 
rabbit-anti-
ETAR-IgG 
polyclonal Alomone Labs, Israel 1:100 
mouse-anti-
calbindin-D28K-
IgG 
monoclonal SWANT, Marly 1:200 
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goat-anti-α-
integrin8-IgG 
polyclonal 
R&D systems, 
Wiesbaden 
1:200 
goat-anti-
aquaporine2-
IgG (C-17) 
polyclonal 
Santa Cruz, 
Heidelberg 
1:200 
goat-anti-CD31-
IgG 
polyclonal 
R&D systems, 
Wiesbaden 
1:200 
second 
antibody 
conjugation company dilution 
donkey anti-
chicken-IgY 
rhodamin-(TRITC) Dianova, Hamburg 1:400 
donkey anti-
chicken-IgY 
Cy2 Dianova, Hamburg 1:400 
donkey anti-
mouse-IgG 
Cy2 Dianova, Hamburg 1:400 
donkey anti-
mouse-IgG 
Cy5 Dianova, Hamburg 1:400 
donkey anti-
rabbit-IgG 
rhodamin-(TRITC) Dianova, Hamburg 1:400 
probes (ISH)  company  
RNAscope® 
negative control 
probe –DapB 
 ACD, Hayward, USA  
RNAscope® 
positive control 
probe –mM-
PPIB 
 ACD, Hayward, USA  
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RNAscope® -
mM-ETBR-C1 
 ACD, Hayward, USA  
BASEscope®-
mM-ETBR-C1 
 ACD, Hayward, USA  
2.2 Methods 
2.2.1 Animals 
All Animals were treated in conformity with ‘National Institute of Health guidelines for the care 
and use of animal research’ and were approved by the local commission of ethics 
(temperature 23°C ± 2°C, relative humidity 55% ± 5%, light/dark interval 12h, food and water 
ad libitum). 
In order to generate a renin cell-specific ETAR-deleted animal model, the established 
Cre/loxP-recombinase system was used for present experiments. ETARflox/flox animals (with 
kind permission of Mr. Yanagisawa, University of Texas Southwestern medical Center at 
Dallas) were initially paired with CreRen1d (with kind permission of Ariel Gomez, University of 
Virginia). The offspring was genetically determined either as ETARflox/flox/RenCreHet or 
ETARflox/flox and ETARflox/flox/RenRen. Whereas ‘RenCreHet’ signifies, that animals possess 
both an active Ren1d-gene and additionally activated CreRen1d-recombinase: Ren1d+/Cre-
ETARfl/fl. ETARflfl/RenRen represents the control littermates where no Cre-recombinase is 
active (ETARfl/fl). 
ETBRflox/flox animals (with kind permission of Miles L. Epstein, University of Wisconsin, 
Madison) were initially paired with CreRen1d. Therefore Ren1d+/Cre-ETARfl/fl was genetically 
determined as knockout mouse with active Cre-recombinase as well as active Ren1d-gene 
and ETBRfl/fl signifies control littermates. 
Further ETARflox/flox and ETBRflox/flox animals were also paired with FoxD1-Cre to activate 
recombinase in stroma-derived cells (commercially acquirable at The Jackson Laboratory, 
Maine USA). In addition both ET-receptors loxP strains were paired, in addition with 
SMMHC-CreERT2 (with kindly permission of Stefan Offermanns, University of Heidelberg) 
where a fusion protein is expressed under the control of the SMMHC-promotor consisting of 
of the Cre-recombinase and a modified estrogen binding site: SMMHC-CreERT2- ETARfl/fl 
and SMMHC-CreERT2- ETBRfl/fl 
ETARflox/flox animals were also paired with CAGG-Cre-ERT2 (commercially acquirable at The 
Jackson Laboratory, Maine USA) where recombinase is active through induction with 
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tamoxifen chow ubiquitous under the control of β-actin promoter/enhancer coupled with the 
cytomegalovirus immediate-early enhancer (CAGG-Cre-ERT2): CAGG-Cre-ERT2-ETARfl/fl-
mice, in order to study if general ETAR expression is involved in the regulation of renin 
synthesis and secretion. All animals possessed a mixed genetic background of 129Sv and 
C57Bl/6.  
Animal strains used for present thesis: 
strain genetic background origin 
C57/Bl6 C57/Bl6 Charles River, Sulzfeld 
CAGG-
Cre-ERT2 
C57/Bl6 Jackson Laboratories 
ETAR 
loxP 
129/SV Masashi Yanagisawa 
ETBR 
loxP 
129/SV Miles L. Epstein, University of Wisconsin 
FoxD1-
Cre 
Bl6/129SV Jackson Laboratories 
Ren-Cre Bl6/129SV 
R. Ariel Gomez, University of Virginia School 
of Medicine 
SMMHC-
Cre-ERT2 
Bl6/129SV Stefan Offermanns, University of Heidelberg 
 
2.2.2 In vivo studies 
Mice used for molecular biological and histological experiments were 90-120 d of age.  
High salt and low salt diet 
In order to modulate RAAS, animals were treated for 14 d with either a high-salt diet (4 % 
NaCl; Ssniff) or a low salt diet (0.02 % NaCl; Ssniff). Low salt diet was in combination with 
the ACE-inhibitor enalapril (10 mg kg-1 day-1; Sigma-Aldrich, St. Louis, MO) dissolved in 
drinking water bottle. Controls were maintained on standard rodent chow (0.4 % NaCl; Ssniff)  
Extraction of kidneys for molecular and histological experiments 
One kidney was used for histological work and therefore a retrograde arterial perfusion was 
performed with 3 % paraformaldehyde in PBS in order to fixate the kidney. Second kidney 
was used for mRNA-studies and subsequently stored immediately at -80° C after cording up 
arteriae renales with a polyglactin suture (Vicryl) to avoid flushing kidney with fixing medium. 
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Retrograde arterial perfusion for IHC 
For this procedure mice were first anesthetized with a solution of ketamine and xylazine (80 
mg/kg BW; i.p.). After opening abdomen, displaced abdominal aorta was clamped 
underneath the outlet of arteriae renales in order to avoid disturbances of blood circulation of 
the kidney. On the next step, catheter of perfusion was inserted distal to the clamp and fixed 
in this position. For pressure equalization, vena cava inferior was opened with the help of a 
scissor. Fixed clamp was then removed and via catheter, 20 ml of isotonic NaCl-solution with 
heparin were perfused retrograde. Afterwards, fixation was performed with 3 % 
Paraformaldehyde in PBS with a constant flow of 50 ml/3 min. Dissected and perfused 
kidneys were stored at 4°C in 70% methanol until paraffin embedding for histological 
experiments.  
Retrograde arterial perfusion for in situ hybridization (RNAscope®): 
Procedure of perfusion for ISH is similar to retrograde arterial perfusion for IHC except 
solution for fixation. Instead of 3 % Paraformaldehyde in PBS a solution based on formalin 
was used for this experiment. Animals were fixated with a constant flow of 50 ml/3 min. After 
dissection of kidneys, organs were stored in this fixation solution for 24 h before proceeding 
ISH (RNAscope®) protocol. 
Solution for fixation (3 animals):  
 25 ml formalin 
 225 ml H20 
 1 g/l NaH2PO4 
 1,625 g/l Na2HPO4 
2.2.3 In vitro/Ex vivo studies 
Isolated perfused mouse kidney model (IPMK) 
The isolated perfused mouse kidney is an important tool for experimental nephrology 
(Schweda et al., 2003; Czogalla et al., 2016) where one can study organ function in the 
absence of systemic influences such as blood pressure, autonomic nervous system or 
several hormones . The combination of in vitro and in vivo (ex vivo) has the ability to examine 
physiological, pharmacology or biochemical aspects of renal function. Therefore kidneys are 
dissected and perfused in a heated moist chamber through renal artery with a constant 
pressure (80-100 mmHg). The perfusate solution is collected through the renal vein for 
measuring renin activity. The perfusate solution is a modified Krebs-Henseleit solution 
containing BSA (6 g/100ml) and human erythrocytes (10 % hematocrit). In order to 
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investigate the effects of ET-1 on the renin secretion rate with different ET-receptor animal 
models, the IPMK is a perfect tool. 
Protocol (after Czogalla et al., 2016): 
1. Buffer Preparation:  
 Prepare the dialysis buffer: 
Solution 1 (10x concentrated): 
NaCl   126 g  107.8 mM 
NaHCO3  46 g  27.4 mM 
KCl   6.6 g  4.42 mM 
Urea   7.3 g  6 mM 
Creatinine  0.5 g  0.132 mM 
Ampicillin  0.3 g 
MgCl2 * 6H20  4 g  1 mM 
add dH20 to a final volume of 2l 
 
Solution 2 (10x concentrated): 
Glucose  15 g  8.32 mM 
Add dH20 to a final volume of 2l 
 
Solution 3 (10x concentrated): 
CaCl2 * 6H20  2.6 g  0.935 mM 
Add dH20 to a final volume of 1l 
 
Solution 4 (10x concentrated): 
NaH2PO4  0.4 g  2.88 mM 
Na2HPO4  1.2 g  0.66 mM 
Add dH20 to a final volume of 1l 
 
Antidiuretic hormone (ADH) solution: 
1µg 
 
Dialysis buffer (composition) 
Solution1  500 ml 
Solution2  500 ml 
Solution3  500 ml 
Solution4  500 ml 
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Aminoplasmal 83 ml 
ADH solution  0.5 ml 
Na-Pyruvate  165 mg 0.3 mM 
Na-Glutamate  262 mg 0.31 mM 
Na-Malate  281 mg 1.15 mM 
α-ketoglutarate 1133 mg 1.2 mM 
Na-Lactate  1176 mg 2.1 mM 
FITC-Inulin  25 mg 
Add dH20 to a final volume of 5l: adjust pH 7.7 
 
Perfusion buffer for one mouse: 
Dialysis buffer 400 ml 
Human erythrocytes to hct of 10 % 
 
 Erythrocyte preparation: dilute 250 ml of human erythrocyte concentration 
(tested material obtained from the local blood bank) to 500 ml with dialysis 
buffer. Centrifuge at 2.000 x g for 8 min. Remove the buffer, being careful not 
to remove any erythrocytes. Repeat 3x 
 Prepare the albumin (BSA) buffer: in 200 ml of dialysis buffer, dissolve 44 g of 
BSA using a stir bar. Filter the solution with filter paper 
 Prepare the perfusate: filter the erythrocytes through filter paper into the BSA 
buffer. Fill up to a total volume of 800 ml with dialysis buffer: Note: the 
hematocrit should be now between 8-12 %. It can be stored for 12hr at 4 °C. 
 
 
2. Initiating dialysis and oxygenation: (Fig. 5) 
 Turn on the water bath surrounding the larger buffer reservoir, smaller buffer 
reservoir and the moist chamber to 37 °C. 
 Fill the larger buffer reservoir with the dialysis buffer and the smaller reservoir 
with the perfusate 
 Turn on 5% CO2/95% O2 gas inflow to the dialysis buffer 
 Switch on continuous dialysis of the perfusate against the dialysis buffer.  
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3. Surgical procedure (part 1) (see Fig.6) 
 Anesthetize mouse with 10 µl/g of body weight, 20mg/ml ketamine and 1 
mg/ml xylazine dissolved in 0.9 % NaCl 
 Fix mouse in the moist chamber. Place a 1 ml syringe below the spine to 
elevate the lumbar vessels 
 Perform a median laparotomy from the pubic crest to the sternum opening first 
the skin, then the abdominal muscles, with scissors 
 Remove the intestine and place it on the left side of the mouse lateral from the 
abdomen 
 Free the bladder from connective tissue and explore both ureters and urethra 
 Place and close ligature I 
 Place and close ligature II 
 Place ligature III 
 Incise the bladder (1 mm) 
 Cannulate the opening with 2 cm PE 50 tubing  
 Close  ligature III around the tubing 
 Cut the left ureter and urethra distal from the ligatures. The bladder is now 
attached to the right ureter only and freely moving 
 Clear the abdominal aorta of connective tissue and fat 
 Place an abdominal mid-aorta ligature (ligature IV) 
 Place a ligature around the aorta below the diaphragm between the superior 
mesenteric artery and the coeliac trunk (lig.V) 
 Place a ligature around the superior mesenteric artery (lig.VI) 
 Place an aortic ligature directly below the right and above the left renal artery 
(lig.VII) 
Fig. 5: Schematic drawing of the perfusion circuit and the direction of buffer flow 
(Czogalla et al., 2016):all components surrounded by blue are kept at 37 °C with a water 
bath (1) dialysis buffer with continuously 95% O2/5% CO2 (2) dialysis tube with roller pump 
to continuously dialyze dialysis buffer and perfusion buffer against each other (3) perfusion 
buffer is enriched with 9% O2/5% CO2 and electrolyte levels are kept constant throughout 
perfusion (4) a roller pump connects perfusion buffer towards the kidney (5) windkessel 
removes peristaltic waves and traps bubbles (6) pressure transducer (7) kidney remains in 
the moist chamber  
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 Place a ligature around the caudal vein package (lig.VIII) 
 
 
 
 
 
 
 
 
 
 
 
 
4. Priming of the perfusion circuit 
 Start the rotary pump and fill the tubing with perfusate. Remove all air bubbles 
 fill the windkessel device to approximately mid-level with perfusate 
 Calibrate the pressure transducer to 0 mmHg when all tubing is filled and flow 
is 0. Keep the perfusion needle at the kidney level during this time 
 Keep flow at constant minimal level (0.6 ml/min) and proceed further 
5. Surgical procedure (part 2) 
 Place a clamp between lig.IV and the branching of the left renal artery 
 Make a small incision in the aorta caudal of lig.IV, do not cut the dorsal wall 
 Dilate the opening in the aorta with a vessel dilator 
 Cannulate the aorta with a needle (ca. 2 cm long, pulled PE 50), pushing the 
tip just to the clamp 
 Open the clamp 
 Push the tip of the needle cranially until it reaches the junction of the right 
kidney artery and the aorta 
 Close lig.VII 
Fig. 6: Schematic drawing of the ligatures placed during surgery 
(Czogalla et al., 2016) 
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 Close lig. IV 
 Open the chest with scissors by dissecting the diaphragm. With a single cut, 
separate the aorta, vena cava, heart and vegetative nerves. 
 Start pressure control of the perfusion pump. Maintain the mean pressure 
between 80-100 mmHg 
 Close lig.V 
 Close lig.VI 
 Close lig.VIII 
 Free the right kidney from connective tissue and its embedding into the adipose 
capsule with scissors 
 Cut the aorta proximally to lig.V 
 Cut the superior mesenteric artery distally to lig.VI 
 Cut the kidney-supporting vessel bundle out, do not cut into the vessels 
themselves 
 Cut the liver at the connection to the kidney. Take care to free the kidney, but 
leave a small part of the liver adherent to it, so that the vena cava is kept open by 
it 
 Take the kidney bundle out of the mouse. Remove the mouse from the moist 
chamber 
 Place ligature around the connection of liver and kidney (lig.IX) 
 Cannulate the vena cava with a venous line (2 cm PE 50) 
 Clos lig.IX. venous outflow through the venous line should immediately start 
 Close the moist chamber 
 
6. Downstream analysis: 
During the following hour, monitor blood flow and intravascular pressure. Collect 
venous outflow which is used for renal renin release 
The renal function is therefore sustainable for at least 1h: 
General results: 
 Vascular resistance, perfusate flow remain steady 
 e.g. glomerular filtration rate: 130 µl/min*g kidney weight 
 fractional sodium and potassium resorption are unchanged 
 all segments of the kidney show no signs of organ damage 
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For present study, this tool allows studying changes regarding renin secretion as reaction to 
ET-1 in increasing concentrations (30,100,300 pM and 1 nM). Every 2 min samples are 
collected for evaluation of renin secretion rate and the activity of renin was measured via 
ANG I ELISA assay afterwards (2.4.4). The rate of renin secretion (ng ANG I/ml*h-1) is 
defined as the activity of renin (ng ANG I/h x min x g) multiplied by renal blood flow 
(ml/g*organ weight*min-1).  
2.3 Histological methods 
2.3.1 Immunohistochemically staining of paraffin embedded kidney sections 
In order to avoid autocatalytic mechanisms and to have a better quality of the sample, kidney 
tissue was fixed before dissection through PFA-retrograde arterial perfusion (see. 2.2.2). 
For the beginning of tissue embedding with paraffin, perfused kidneys were dehydrated with 
an ascending methanol series [2x (70 %, 80 %, 90 % and absolute) for 30 min]. Afterwards, 
kidneys were washed in absolute isopropyl alcohol 2x 30 min at room temperature and 
additionally stored in an isopropyl alcohol/paraffin- composite (1:1; 55°C) for another 30 min. 
Subsequently, kidneys were incubated for 2x24 h at 60°C in paraffin and then transferred 
into silicon-rubber- embedding forms where they cured overnight.  
With the help of a rotation microtome, paraffin slices were cut (5 µm), transferred in a 40 °C 
water bath and taken up by a microscope slide. In the end, paraffin slides were dried for 12 h 
in a dry chamber (40°C). 
When performing immunofluorescent staining, deparaffining steps were necessary after 
protocol in advance: 
 2 x xylol 10 min 
 2 x isopropyl alcohol absolute; 5 min 
 isopropyl alcohol 96 %; 5 min 
 isopropyl alcohol 80 %; 5 min 
 isopropyl alcohol 70 %; min 
2.3.2 Immunofluorescent staining 
After paraffin embedding of the tissue, kidney slides were stained with the help of indirect 
immunofluorescence. This method uses the specificity of antibodies to their antigen to target 
fluorescent dyes to specific targets, and therefore allows visualization of the target molecule. 
An unlabeled first antibody is used for binding specifically to the target molecule and the 
second antibody carries the fluorophore, recognizing the first antibody and binds to it. It 
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should be noted the second antibody complies with antigen sequences of host from first 
antibody. 
Protocol for immunofluorescent staining of tissue (paraffin): 
 wash slides with kidney sections 3 x for 5 min with PBS 
 according to requirements of antibody: unmasking tissue while incubating with 
Tris/EDTA for 45 min at 97 °C in water bath 
 2 x washing with PBS for 5 min each 
 Incubate with blocking solution 4 % milk powder in PBS  for weakening unspecific 
binding: 1 h at RT 
 Incubate with first antibody (diluted in blocking solution) in a moist chamber over night 
at 4°C 
 3 x washing with 4 % milk powder in PBS for 5 min each 
 Incubate with second antibody (flurophore conjugated antibody; 1:400): 90 min at RT 
in a moist chamber (dark surrounding)  
 3 x washing with PBS for 5 min each 
 Embedding sections with glycergel mounting medium 
 Overview: 
staining ETAR, renin, α-sma 
tissue paraffin sections 5 µm 
demasking TrisEDTA, pH8.5, 1h, 95°C 
blocking solution 5% Milk powder in PBS, 1h, RT 
first antibodies (ON) 
rabbit anti-ETAR 
(1:100) 
chicken anti-renin 
(1:400) 
mouse anti-α-sma 
(1:400) 
diluted solution 5% milk powder in PBS 
second antibodies (90 min) 
Cy2 donkey anti-rabbit 
TRITC donkey anti-chicken 
Cy5 donkey anti mouse 
(1:400) 
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2.3.2 Microscopy 
Acquisition of fluorescent stainings was provided with Colibri.2 and Axio Observer Z1 
microscope with motorizing object holder from Zeiss. With the help of Zen software from 
Zeiss (Zen 2012), pictures were digitalized and edited. In order to avoid weakening of quality, 
TIFF format was used for present thesis. 
2.4 Molecular biology 
2.4.1 Polymerase chain reaction assays for genotyping 
With the help of the polymerase chain reaction used mice were tested for positive 
transgenical allele. Therefore 0.5 cm of the mouse tail were digested for 1 h with 100 µl 25 
mM NaOH solution and deactivated with 10 µl of 1 M of Tris-HCl solution 
PCR-approach (25 µl) 
10x buffer 5 µl 
Tag Polymerase 0.3 µl 
dNTPS 2 µl 
sense primer (10pmol/µl) 1 µl 
antisense primer (10pmol/µl) 1 µl 
dd H20 13.7 µl 
DNA-template 2 µl 
∑ 25 µl 
  Table 2: PCR approach (25 µl) 
 
 
program for cycler 
step temperature duration repeat 
1. Initial Denaturation 94 °C 5 min  
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2. Denaturation 94 °C 30 sec  
 
         36 x 3. Annealing variable 30 sec 
4. Elongation 72 °C 1 min 
5. Final Elongation 72 °C 5 sec 
6. Hold 15 °C ∞  
 Table 3: PCR program 
 
PCR: Annealing temperature for different genotype PCR 
ETAR loxP 60 °C 
ETBR loxP 66 °C 
FoxD1-Cre 58 °C 
Ren-Cre 56 °C 
SMMHC-Cre 62 °C 
CAGG-Cre 
(TamCre) 
65 °C/ 55 °C 
Table 4: Annealing temperature of different PCR approaches 
2.4.2 Gel electrophoreses 
After running the polymerase chain reaction (PCR) the size of the resulting amplicon could 
be determined through gel electrophoresis.  
Therefore 1 g of agarose was completely dissolved in 100 ml 1x TAE-Buffer through cooking 
in a microwave for 3 min. After cooling down to 60 °C, 3 µl of a non-toxic stain solution 
(Roti®-GelStain) were added to the approach. The electrophoresis chamber was filled up 
with 1x TAE-Buffer after gel was cured. Present samples were applied on the gel and 
electrophoreses could be performed for 45 min on 130 V. After fractionation of DNA, gel was 
removed out of the chamber and monitored with a camera system under UV-light irradiation 
in a trans illuminator. 
2.4.3 Expression studies 
In order to examine the potential role of ETAR and/or ETBR through ET-1 on the renin 
system in vivo, expression studies were implemented via quantitative real-time RT-PCR-
analyses of kidneys from different animal models. After harvesting kidneys from animals, 
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next step was to isolate whole RNA from tissue first. In addition, transformation into cDNA 
and subsequently quantitative real-time RT-PCR was performed. 
2.4.3.1 Isolation of RNA from tissue 
After harvesting the kidneys out of the rodents, organs were stored in peqGOLD TriFastTM-
reagent (Trizol) in order to macerate tissue. With the help of a homogenizer, organs were 
homogenized. Trizol is a monophasic solution with guanidinium thiocynate and phenol. By 
the use of chloroform, present homogenized suspension is separated into three parts: A red 
phenol-chloroform-part on the bottom of the cup, a white interphase and a colorless aqueous 
part on the top. The RNA appears exclusively in the top part und can be precipitate with 
isopropyl alcohol. 
Protocol for RNA-Isolation with TriFastTM-reagent 
 1000 µl (for ½ kidney) TriFastTM reagent 
 homogenize tissue for 30 sec 
 adding 200 µl chloroform, shake gently 
 10 min incubate at room temperature 
 centrifuge samples for 15 min at 12.000 g (4°C) 
 transfer colorless aqueous part on the top into new cup 
 adding 500 µl isopropyl alcohol, vortex 
 centrifuge samples for 10 min at 12.000 g (4°C);  remove supernatant 
 washing pellet with 1 ml 75 % ethanol (2 x) 
 centrifuge samples for 10 min at 12.000 g (4°C) 
 dry pellet for 20 min under hood 
 solve pellet in 300 µl DEPC-water (for ½ kidney) 
 2 min on shaker, 65 °C 
 measure concentrations with NanoDrop (1 µl); storage at -80°C  
The concentration of isolated RNA was measured with a photometer. To determine the 
clearance of each sample, extinction value at 260 and 280 nm wavelengths against RNAase 
free water was ascertained. The reference range from E260/280 was defined between 1.80 and 
2.00.  
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2.4.3.2 cDNA synthesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RNA can be transformed into cDNA with the help of the enzyme reverse transcriptase. In 
order to transcribe primarily mRNA with a polyA-tail, oligo-dT-chains were used for this 
procedure. 
The cDNA-synthesis proceeds at 37 °C. Inactivation of reverse transcriptase expires at 
85 °C. Present cDNA was stored at -20 °C for quantitative real-time RT-PCR-analyses. 
2.4.3.3 Quantitative real-time RT-PCR 
The complementary DNA (cDNA) serves as a raw material for established quantitative real-
time RT-PCR. It is first synthesized over reverse transcriptase out of mRNA.  In order to 
amplify a prospecting transcript, normal PCR-program with specific primers is implemented. 
To quantify the expression of certain transcripts, the exponential enhancement of the product 
is measured continuously and fluorescent based. A fluorescent dye (SYBR-Green) is used, 
which can intercalate into the PCR-products and is innervated by a laser. The intensity of the 
emitted fluorescence is ascertained by a detector. This so-called fluorescent intensity is 
approach  
1 µg RNA var. 
oligo-dT 1 µl 
nuclease-free water add to 10 µl 
5 min, 65 °C 
thermocycler 
 
approach 12 µl/sample 
dNTP (2.5 mM) 4 µl 
5x Buffer 4 µl 
reverse transcriptase 1 µl 
nuclease-free water 3 µl 
1 h 37 °C, 2 min 
95 °C, ice 
 
Table 5: RT-PCR approach 
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adequate to the present amount of DNA because the fluorescent dye embeds exclusively 
into double-stranded DNA and when uncombined it achieves a weak fluorescent signal. 
Therefore the amount of products can be traced during running of the program.  
The cT-value (cycle threshold) states the number of cycles where fluorescence exceeds 
above the background. At this point the exponential increase of the product is able to be 
monitored. In addition the cT-value is dependent on applied cDNA concentration of the 
examined gene. A quantitative evaluation of the original mRNA amount is therefore possible. 
After amplification, a melting curve is created to delimit possible primer dimers from specific 
product.   
The target gene is set on ratio to a reference gene in terms of the relative quantification. 
Typical constitutive ‘housekeeping genes’ are expressed in all cells of an organism and 
relatively constant in their level of expression.  
2.4.3.4 Running the quantitative real-time RT-PCR 
Expression studies were performed with different kidneys from existing animal models via 
quantitative real-time RT-PCR. The analysis was carried out by the Lightcycler LC480, 
Roche Detection System with common 96-well-plate system. In order to detect dsDNA from 
each specific transcript, a fluorescent-dye (SYBR Green) was used for samples.  
For relative quantification and therefore normalizing the amount of cDNA, GAPDH and 
RPL32 were used as reference genes.  
Master-Mix approach per well 
SYBR Green MM 5 µl 
Primer Forward (10mM) 0.5 µl 
Primer reverse 0.5 µl 
H20 (RNase free) 3 µl 
cDNA 1 µl 
 ∑ 10 µl 
                                 Table 6: Approach quantitative RT-PCR 
The 96-well-plate was sealed with a special film and centrifuged for 2 min with 2500 g before 
running RT-PCR. 
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Step Number of cycles Temperature Time 
Activation 11 95 °C 15 min 
Denaturation 
Annealing 
Elongation 
 
40 
95 °C 
58 °C 
72 °C 
15 s 
20 s 
20 s 
 Table 7: Program for quantitative RT-PCR 
Data was collected with LightCycler 480 SW 1.5 software and evaluated with Microsoft Office 
Excel. Relative cDNA levels X regarding the Target gene were normalized to the cT-value of 
the reference gene and to the standard conditions.  
2.4.4 ELISA assay for plasma renin concentration (PRC) 
The transformation of Angiotensinogen into ANG I is catalyzed by renin. The amount of renin 
is proportional to emerging amount of ANG I. Therefore a direct Enzyme-linked 
Immunosorbent Assay (ELISA-kit) of ANG I was performed to determine quantitatively the 
plasma renin concentration.   
The kit measures plasma renin activity (PRA) in terms of mass of Ang-I generated per 
volume of mouse plasma in unit time (ng/ml). All solutions needed for present methods are 
included in given kit. 
Before running assay procedure, required amount of blood need to be collected from animals 
in plastic-hematocrit-capillaries coated with EDTA in order to avoid hemostasis.  
ELISA-method in general involves at least one antibody with specificity for a particular 
antigen. Each sample with an unknown amount of antigen is transferred on the surface of a 
polypropylene test tube. During the first incubation unlabeled ANG-I compete with 
biotinylated Ang-I to bind to the anti-Ang-I antibody. In the second incubation the labelled 
Streptavidin-HRP conjugate, binds to immonilized Ang-Biotin. Unbound material is removed 
with various washing steps. The colorimetric HRP substrate is added and after stopping the 
color development reaction, the light absorbance (OD) is measured with a microtiter plate 
reader. The absorbance values are inversely proportional to the concentration of Ang-I in the 
sample. In order to plot a standard curve a set of calibrators is used.  
Protocol for Ang-I ELISA (PRA): 
 collect blood in plastic-hematocrit-capillaries coated with EDTA 
 centrifuge capillaries for 4 min at room temperature at 8000 rpm 
 transfer plasma sample to cup at room temperature 
 dilute samples in Maleate buffer 1:50 
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 add PMSF (1:100), renin substrate and generation buffer (1:10) 
 divide samples into cold- and warm value:  
warm value: 90 min at 37°C 
cold value: 90 min on ice (4°C) 
 45 µl of each sample and standard solutions transfer into 96-well plate 
 add 100 µl of Biotin-conjugate solution into each well, incubate 1 h at RT (200 rpm 
with shaker) 
 5 x washing step with washing buffer 
 add 150 µl of Streptavidin-HRP in each well, incubate 30 min at RT (200 rpm) 
 5 x washing step with washing buffer 
 add 150 µl of TMB-substrate in each well, incubate for 15 min at RT 
 add 50 µl of stop solution, measurement of samples at 450 nm 
2.4.5 In situ hybridization RNAscope® and BASEscope® 
In situ hybridization was realized by RNAscope® Reagent Kit (brown) and BASEscope® 
Detection Reagent Kit (red) and RNAscope® 2.5 Duplex Detection kit from Advanced Cell 
Diagnostics. Therefore a retrograde arterial perfusion was performed after protocol (see 
2.2.2) and kidneys were dissected afterwards. ISH-assays are able to detect nucleic acids on 
the tissue. Due to lack of working antibody for ETBR, we could detect ETBR mRNA signal in 
kidney slides of different animal models. 
Solution for Fixation (FFPE sample preparation):  
 25 ml formalin 
 225 ml H20 
 1 g/l NaH2PO4 
 1.625 g/l Na2HPO4 
Paraffin embedding procedure of kidneys after following protocol: 
 2x 70 % EtOH p.a. 
 2x 80 % EtOH p.a. 
 2x 90 % EtOH p.a. 
 1x 100 % EtOH p.a. 
 1x 100 % isopropyl alcohol 
 1x 100 % isopropyl alcohol (45 °C); 45 min 
 1x 1:1 Isopropyl alcohol/paraffin-composite (60 °C; 45 min) 
 2x 24 h incubate in paraffin (60 °C) 
 
30 min on shaker 
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With the help of a rotation microtome, paraffin slices were cut (5/7 µm), transferred in a 40 °C 
water bath and taken up by a microscope slide. In the end, paraffin slides were dried for 12 h 
at RT. 
Deparaffine and preparation for ISH RNAscope® and BaseScope® method: 
 Microscope slides with paraffin slices for 1 h in dry oven at 60 °C 
 2 x 10 min in Xylol at RT 
 2 x 2 min in EtOH p.a. at RT 
 air dry slides for 5 min at RT 
 prepare 1 x RNAscope® Target Retrieval Reagents  
 apply RNAscope® Hydrogen Peroxide on slides (10 min) 
 2 x H20 RNase free washing step 
 apply RNAscope® Target Retrieval Reagents (15 min) 
 2 x H20 RNase free washing step 
 1 x 2 min in EtOH p.a. at RT 
 air dry slides ON at RT 
 draw barrier around each section with hydrophobic barrier pen 
RNAscope® 2.5 assay 
 prepare all materials after manual guideline (oven, water bath, target probes,washing 
buffer) 
 apply RNAscope® Protease Plus (30 min) at 40°C in oven 
 wash with H20 RNase free 
 apply RNAscope® Target probe  (mM-ETAR, mM-ETBR) for 2 h at 40°C 
 2 x 2 min washing step with RNAscope® washing buffer 
 Hybridize signal amplification molecule (AMP 1) for 30 min at 40°C 
 2 x 2 min washing step with RNAscope® washing buffer 
 Hybridize signal amplification molecule (AMP 2) for 15 min at 40°C 
 2 x 2 min washing step with RNAscope® washing buffer 
 Hybridize signal amplification molecule (AMP 3) for 30 min at 40°C 
 2 x 2 min washing step with RNAscope® washing buffer 
 Hybridize signal amplification molecule (AMP 4) for 45 min at 40°C 
 2 x 2 min washing step with RNAscope® washing buffer 
 Hybridize signal amplification molecule (AMP 5) for 30 min at RT 
 2 x 2 min washing step with RNAscope® washing buffer 
 Hybridize signal amplification molecule (AMP 6) for 30 min at RT 
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 Detection of signal with DAB-A and DAB-B solution after manual guidelines (1:1; 10 
min) 
 2 x 2 min 50 % hematoxylin staining solution (Gill’s hematoxylin) 
 3 x washing step with H20 RNase free until slides are clear 
 1x 10 sec 0.02 % ammonium hydroxide-solution  
 3-5 times with H20 RNase free washing step 
 mount slides and place coverslip over the section (air dry > 5 min) 
BASEscope® Detection Regant Kit-Red 
 prepare all materials after manual guideline (oven, water bath, target probes,washing 
buffer) 
 apply BASEscope® Protease III (30 min) at 40°C in oven 
 wash with H20 RNase free 
 apply BASEscope® Target probe  (mM-ETBR) for 2 h at 40°C 
 2 x 2 min washing step with BASEscope® washing buffer 
 Hybridize signal amplification molecule (AMP 0) for 30 min at 40°C 
 2 x 2 min washing step with BASEscope® washing buffer 
 Hybridize signal amplification molecule (AMP 1) for 15 min at 40°C 
 2 x 2 min washing step with BASEscope® washing buffer 
 Hybridize signal amplification molecule (AMP 2) for 30 min at 40°C 
 2 x 2 min washing step with BASEscope® washing buffer 
 Hybridize signal amplification molecule (AMP 3) for 30 min at 40°C 
 2 x 2 min washing step with BASEscope® washing buffer 
 Hybridize signal amplification molecule (AMP 4) for 15 min at 40°C 
 2 x 2 min washing step with BASEscope® washing buffer 
 Hybridize signal amplification molecule (AMP 5) for 30 min at RT 
 2 x 2 min washing step with BASEscope® washing buffer 
 Hybridize signal amplification molecule (AMP 6) for 15 min at RT 
 Detection of signal with RED-A and RED-B solution after manual guidelines (1:60;10 
min) 
 2 x 2 min 50 % hematoxylin staining solution (Gill’s hematoxylin) 
 3 x washing step with H20 RNase free until slides are clear 
 1x 10 sec 0.02 % ammonium hydroxide-solution  
 3-5 times with H20 RNase free washing step 
 Incubate for 15 min in dry oven at 60 °C 
 Mount slides and place coverslip over the section (air dry > 5 min) 
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RNAscope® 2.5 Duplex Detection kit: 
 prepare all materials after manual guideline (oven, water bath, target probes, washing 
buffer) 
 apply RNAscope® Protease Plus (30 min) at 40°C in oven 
 warm probes for 10 min at 40°C; mix 1:50 ratio of C2 (PDGFRβ) probe to C1 (ETBR) 
probe 
 put mixture for 2 h at 40°C in the oven 
 2 x 2 min washing step with RNAscope® washing buffer 
 Hybridize signal amplification molecule (AMP 1) for 30 min at 40°C 
 2 x 2 min washing step with RNAscope® washing buffer 
 Hybridize signal amplification molecule (AMP 2) for 15 min at 40°C 
 2 x 2 min washing step with RNAscope® washing buffer 
 Hybridize signal amplification molecule (AMP 3) for 30 min at 40°C 
 2 x 2 min washing step with RNAscope® washing buffer 
 Hybridize signal amplification molecule (AMP 4) for 15 min at 40°C 
 2 x 2 min washing step with RNAscope® washing buffer 
 Hybridize signal amplification molecule (AMP 5) for 30 min at RT 
 2 x 2 min washing step with RNAscope® washing buffer 
 Hybridize signal amplification molecule (AMP 6) for 15 min at RT 
 2 x 2 min washing step with RNAscope® washing buffer 
 Detection of RED Signal (1:60 Red-B to Red-A); 10 min at RT on slides 
 Hybridize signal amplification molecule (AMP 7) for 15 min at 40°C 
 2 x 2 min washing step with RNAscope® washing buffer 
 Hybridize signal amplification molecule (AMP 8) for 30 min at 40°C 
 2 x 2 min washing step with RNAscope® washing buffer 
 Hybridize signal amplification molecule (AMP 9) for 30 min at 40°C 
 2 x 2 min washing step with RNAscope® washing buffer 
 Hybridize signal amplification molecule (AMP 10) for 15 min at RT 
 2 x 2 min washing step with RNAscope® washing buffer 
 Detection of Green Signal (1:50 Green-B to Green-A); 10 min at RT on slides 
 2 x 2 min 50 % hematoxylin staining solution (Gill’s Hematoxylin) 
 3 x washing step with H20 RNase free until slides are clear 
 1x 10 sec 0.02 % ammonium hydroxide-solution  
 3-5 times with H20 RNase free washing step 
 incubate for 60 min in dry oven at 60 °C 
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 mount slides and place coverslip over the section (air dry > 5 min) 
 
For additional staining (IHC) with antibodies after RNAscope® 2.5 assay and BASEscope® 
assay 
 after last washing step with H20 RNase free; slides were incubated for 3 x 10 min in PBS 
 incubate with blocking solution (10 % horse serum in 1 % BSA/PBS-Otto) for 1 h at RT 
 incubate with first antibody (diluted in blocking solution) in a moist chamber over night at 
4°C 
 3 x washing with 1 % BSA/PBS-Otto for 5 min each 
 incubate with second antibody (fluorophore conjugated antibody; 1:400): 90 min at RT in 
a moist chamber (dark surrounding)  
 3 x washing with PBS-Otto for 5 min each 
 embedding sections with glycergel mounting medium 
2.5 Analyzing and statistics 
The program Microsoft® Excel (Microsoft® Corporation, Redmond, USA) was used for 
analyzing numeric data. General ‘Students T-Test’ was performed for statistical analysis 
whereas significant differences were presumed as p < 0.05 (*) and highly significant 
differences as p < 0.01 (**). Statistical difference compared to controls was marked directly 
above SEM (standard error of the mean)-bar. The software GraphPad Prism 5 was used for 
all presented graphs. 
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3 Results 
3.1 Localization of ETA- and ETB-receptor in the adult murine kidney  
In order to study the potential role of ETA- and/or ETB-receptor for the renin synthesis and 
secretion in vivo and in vitro localization of ET receptors in the mouse kidney was provided 
by immunofluorescence staining for ETAR and due to the lack of a working antibody by in 
situ hybridization RNAscope/BASEscope® assay for the ETBR (protocol 2.3 and 2.4.5).  
ETAR expression was localized on renin producing cells (Fig.7A) regardless of whether renin 
cells were localized in classical juxtaglomerular or in recruited or ectopic position (Fig.7B,C). 
These findings indicate ETAR as a general marker of renin producing cells in the kidney. 
Furthermore, slight ETAR expression could be detected on mesangial cells (Fig.8B) whereas 
smooth muscle cells (Fig.8A), distal tubular structures (Fig.8C) and collecting duct cells 
(Fig.8D) (Table 8) show strong expression for ETAR. 
 
 
Fig. 7: ETA receptor localization on renin cells 
of adult murine kidney (A) ETAR expression co-
localized on rpcs, scale bar = 10 µm, renin, WT (B) 
ETAR expression co-localized on recruited rpcs 
(renin) alongside afferent arteriole; after 2 weeks of 
low salt/enalapril diet, scale bar = 20 µm, WT (C) 
ETAR expression co-localized on ectopic expressed 
rpcs (renin), Cx40
-/-
x Aldo
-/-
, scale bar = 20 µm 
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In order to localize the expression of ETBR in the adult murine kidney, experiments with ISH 
RNAScope/BASEscope® assay from ACD were performed (Fig.9,10). ETBR mRNA signals 
could be localized not only on renin producing JG cells (Fig.9A), but additionally on recruited 
renin producing cells as shown in Fig.9B. Similar to ETAR, the ETB-receptor seems to be a 
general marker for renin positive cells, too. 
 
Fig. 9: Localization of ETBR on renin cells of adult murine kidney of WT kidney sections with ISH 
technique RNAscope® and Basescope®; ETBR mRNA signal detection co-localized on (A) rpcs (renin), 
scale bar = 10 µm (B) recruited renin positive cells (renin) after 2 weeks of low salt/enalapril diet; scale bar = 
10 µm 
Fig. 8: ETA receptor localization in the adult murine kidney (A) ETAR expression co-localized on smooth 
muscle cells (α-sma), scale bar = 20 µm (B) ETAR expr. co-localized on mesangial cells (α-integrin-8), scale bar 
= 10 µm, WT) ETAR expression co-localized on distal tubular structures (calbindin), scale bar = 50 µm, WT (D) 
ETAR expr. co-localized on collecting duct cells (AQP2), scale bar = 50 µm, WT  
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Moreover, ETB-receptor is known to be widely distributed in the kidney. ETB receptor mRNA 
signal could be detected on mesangial cells (Fig.10A), distal tubular cells (Table 8), proximal 
tubular cells (Table 8), cortical and medullary endothelial cells (Fig.10C,D), cortical and 
medullary collecting duct cells (Table8), smooth muscle cells (Table 8) and interstitial cells 
(Fig.10B) on mouse kidney sections.  
As mentioned above, ETBR mRNA signal could also be detected in cortical and medullary 
interstitial cells. Co-localization analysis with RNAscope® DUPLEX assay could detect ETBR 
expression widely distributed on PDGFRβ+ cells, a marker for pericytes (Fig.10B). However, 
it should be noted at this juncture, that not all renal PDGFRβ+ cells express ETBR signal and 
vice versa. 
 
 
 
 
Fig.10: Localization of ETBR in the adult murine kidney of WT kidney sections with ISH technique 
RNAscope® and Basescope®; ETBR mRNA signal detection co-localized on (A) mesangial cells (integrin-8), 
scale bar = 20 µm (B) Duplex Assay RNAscope® ISH; ETBR mRNA signal on interstitial cells (PDGFRβ), scale 
bar = 20 µm (C) cortical endothelial cells (CD31), scale bar = 10 µm (D) medullary endothelial cells (CD31), 
scale bar = 20 µm  
 
 
glom 
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The location as well as the quantity of ETA- and ETB-receptor expression in the murine 
kidney is summarized in Table 8. 
Table 8: Localization and quantity of ETA- and ETB-receptor expression in the adult murine kidney after 
analysis; immunohistochemistry and in situ hybridization RNAscope/BASEscope technique assay; ++ 
strong expression; + weak expression 
 
3.2 Role of ETA-receptor isoform on renin synthesis and secretion in 
vivo 
3.2.1 Verification of renin cell-specific deletion of ETAR (Ren1d+/Cre-ETARfl/fl)  
In order to study the potential direct effect of ET-1/ETA-receptor pathway for the renin 
synthesis and secretion it was necessary to generate a renin cell-specific ETAR animal 
model with the help of the Cre/loxP system (ETAR loxP animals used for present study with 
kind permission of Yanagisawa M. from Howard Hughes Medical Institute, University of 
Texas Southwestern Medical Center, Dallas USA; Ren1d+/Cre animals were used with kind 
permission of Gomez RA from University of Virginia, Charlottesville, USA). Due to the strong 
expression of ETA-receptor on renin producing JG cells and the fact that ET-1 inhibits renin 
in a Ca2+-dependent manner, it was inevitable to hypothesize a potential direct inhibiting role 
of ETAR on renin synthesis and secretion. Therefore, mice genotyped as Ren1d+/Cre-ETARfl/fl 
were considered as knockout animals with loss of ETAR exclusively on renin producing cells. 
Whereas mice with no active Cre-recombinase were determined as control animals (Ren1d+/+-
renal cells ETA-receptor 
ETB- 
receptor 
renin producing JG cells ++ ++ 
smooth muscle cells ++ + 
mesangial 
cells 
extraglomerular + - 
intraglomerular + ++ 
endothelial cells - ++ 
proximal tubular cells - + 
distal tubular cells ++ + 
collecting duct 
cortical ++ ++ 
medullary + + 
interstitial cells 
cortical - + 
medullary - ++ 
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ETARfl/fl or ETARfl/fl). In order to proof present deletion on renin producing cells, IHC with 
given antibodies was performed on paraffin embedded kidney sections (Fig.11). The efficacy 
of deletion could be verified after analyzing the section with the fluorescent microscope. The 
ETAR expression only lacked on renin producing juxtaglomerular cells in Ren1d+/Cre-ETARfl/fl 
animals compared to control littermates (ETARfl/fl) (Fig.9), whereas it was maintained on 
smooth muscle cells, mesangial cells and tubular structures.  
 
3.2.2 Characterization of potential direct effect of ETAR on renin synthesis and 
secretion in vivo  
In order to study a potential direct effect of ETAR on the level of renin producing cells on the 
renin synthesis and secretion in vivo, relative mRNA abundance, plasma renin concentration 
levels and systolic blood pressure was detected under basal conditions first. The results 
showed that relative renin mRNA abundance (Fig.12A) and plasma renin concentration 
(Fig.12B) were unchanged in Ren1d+/Cre-ETARfl/fl compared to control littermates. In addition, 
Ren1d+/Cre-ETARfl/fl had normal systolic blood pressure values (144 ± 1.920) relative to 
ETARfl/fl animals (139.1 ± 1.818) (Fig.10C) and as mentioned in 3.2.1 normal developed 
juxtaglomerular cells under basal conditions after performing immunohistochemistry on 
kidney sections.  
 
 
A. 
C. 
Fig. 11: Verification of renin cell-specific deletion of ETAR on kidney sections (A) ETAR
fl/fl 
 as controls; with 
ETAR, renin, scale bar = 10 µm (B) Ren
1d+/Cre
-ETAR
fl/fl
;ETAR, renin, scale bar = 10 µm after a two week low salt + 
enalapril diet; ETAR expression only lacks on rpcs 
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In order to investigate the role of ETA-receptor on the physiological regulation of the renin 
system, Ren1d+/Cre-ETARfl/fl animals got a two week low salt diet (0.02 % NaCl) with ongoing 
enalapril intake to stimulate renin expression and therefore RAAS. A diet with low 
concentration of sodium leads to a stimulation of RAAS and therefore to a retrograde 
recruitment of renin producing cells along the afferent arteriole and an increased number of 
renin positive cells. In order to study the role of ETA-receptor on the suppression of RAAS, 
Ren1d+/Cre-ETARfl/fl mice got a 2 week high salt diet (4 % NaCl).The chronic modulation of the 
renin system (Fig.13 A,B) , especially feeding animals with a low salt diet increased renin 
mRNA abundance 4-fold and PRC 12-fold, without any difference between controls and 
Ren1d+/Cre-ETARfl/fl. Whereas feeding a high salt diet lowered PRC values by 69% without any 
Fig.12: Characterization of potential role of ETAR isoform expressed on rpcs on renin system in vivo 
(A) relative renin mRNA abundance, (B) plasma renin concentration and (C) blood pressure measurement 
via tail cuff method was unchanged in Ren
1d+/Cre
-ETAR
fl/fl
 compared to controls (ETAR
fl/fl
) under basal 
conditions; n=5 
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difference between the two genotypes (Fig.13 A,B). Untreated adult Ren1d+/Cre-ETARfl/fl mice 
had similar renin mRNA and PRC levels compared to controls.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.3 Role of ETA-receptor on the renin cell lineage for renin secretion in vitro 
With respect to previous findings, the ETA-receptor has no essential role on the renin 
synthesis in vivo. Therefore it was inevitable to further investigate the role of ETAR located 
on renin producing cells for renin secretion in vitro. 
In the isolated perfused kidney model (2.2.3) of control animals (ETARfl/fl ) ET-1 was added to 
the ex situ system with increasing concentrations (30 pM, 100 pM, 300 pM and 1 nM ET-1), 
Fig. 13: Characterization of potential role of ETAR isoform expressed on rpcs on stimulated and 
suppressed renin system in vivo (A) relative renin mRNA abundance, (B) plasma renin concentration and was 
unchanged in Ren
1d+/Cre
-ETAR
fl/fl
 compared to controls (ETAR
fl/fl
) under basal conditions and under low and high 
salt diet for two weeks; a low salt diet lead to an significantly increase of renin mRNA abundance and PRC levels 
with no difference in both groups; whereas a high salt diet leads to an slightly decrease of renin mRNA and PRC 
level in both genotypes; p<0.05;n=5 
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resulting in an inhibition of renin secretion (Fig.14A). It should be mentioned at this juncture 
that the renin secretion is the product of renal blood flow and renin concentration (data not 
shown).The inhibition of renin secretion is mainly mediated through a reduction of renal blood 
flow (ml/g*organ weight*min-1) (Fig.14B). In adult Ren1d+/Cre-ETARfl/fl animals, similar effects 
could be determined. The deletion of ETAR on renin producing JG cells did not markedly 
influence the inhibition of renin secretion through ET-1. Whereas renin secretion rate was 
declined to 80 % in Ren1d+/Cre-ETARfl/fl compared to a decrease of 90 % in controls. Further, 
the inhibition of renin secretion was mainly mediated by a decline of the renal blood flow. The 
flow decreases through ET-1 from nearly 10 ml/min*g to 2 ml/min*g organ weight. Whereas 
renin concentration (ANG I/ml*h) was unchanged in both genotypes after adding ET-1 to the 
system (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.4 Characterization of renal ETA-receptor isoform and its potential indirect 
effects on renin synthesis and secretion in vivo 
All measured in vivo parameters mentioned in 3.2 indicate for the first time that ETAR seems 
to be of less relevance for the physiological relevance of renin synthesis and secretion in 
vivo. Furthermore, this study suggests rather no essential direct effect of ETAR isoform on 
Fig. 14: Isolated perfused kidneys of 
Ren
1d+/Cre
- ETAR
fl/fl
 and controls 
displayed an inhibition of (A) renin 
secretion via adding ET-1 in increasing 
concentrations  (B) decline of renal blood 
flow due to ET-1;flow mainly mediates 
inhibition of renin secretion; iso = 
isoproterenol; experiment was performed 
on constant perfusion pressure 
A. 
B. 
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the level of renin positive cells in vivo and due to results in the isolated perfused kidney in 
vitro. Therefore, it was necessary to further study a potential indirect effect of renal ETA 
receptor isoform for renin synthesis and secretion in vivo.  
Besides the renin producing JG cell area at the vascular pole of the glomerulus, the ETAR is 
suggested to be also expressed on smooth muscle cells, distal tubular cells, collecting duct 
cells and mesangial cells in the kidney (as already mentioned in 3.1.1). In order to study a 
potential general indirect effect of ETAR on the renin system in vivo, additional mouse 
models were generated a priori to further understand the crucial role of renal ETAR 
expression on the renin system. 
3.2.4.1 The potential indirect role of renal ETA-receptor isoform on renin 
synthesis and secretion in vivo 
To investigate, if the potential role of ETAR for the control of renin synthesis and secretion is 
based on stroma derived cells in the kidney, ETAR loxP mice were paired with animals 
holding Cre activation under the control of FoxD1 promotor. All stroma derived cells possess 
this specific promotor including renin positive JG cells, fibroblasts, pericytes, smooth muscle 
cells and mesangial cells. Due to renal ETA-receptor isoform expression, FOXD1Cre/+- ETARfl/fl 
kidneys immunoreactivity of ETAR was lacking on renin producing cells, smooth muscle cells 
and mesangial cells only compared to controls (ETARfl/fl) (Fig. 15A). 
In order to examine, if the potential role of ETAR expressed in the vasculature system for 
renin synthesis and secretion is regulated by systemic factors such as the blood pressure, 
mice with inducible Cre-ERT2 activation under the control of smooth muscle myosin (Myh11) 
promotor were paired with ETAR loxP animals in order to generate SMMHC-Cre-ERT2- 
ETARfl/fl mice. All Cre-ERT2 kidneys showed ETAR immunoreactivity lacking on smooth 
muscle cells only (Fig. 15B) 
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All FOXD1Cre/+- ETARfl/fl animals displayed normal developed renin producing JG cells, 
unchanged renin mRNA abundance, PRC levels as well as similar systolic blood pressure 
values compared to controls (Fig. 16). These given results indicate, that deletion of ETAR on 
renin producing cells, mesangial cells, smooth muscle cells has no significant indirect effect 
on the regulation of renin synthesis and secretion.  
All SMMHC-Cre-ERT2- ETARfl/fl kidneys showed ETAR immunoreactivity lacking in smooth 
muscle cells only (Fig. 15B). In addition, all SMMHC-Cre-ERT2- ETARfl/fl animals showed 
normal developed JG cells, slightly decreased renin mRNA abundance and unchanged 
systolic blood pressure values and PRC levels (Fig. 16) compared to controls (ETARfl/fl). 
 
 
 
 
 
Fig. 15: Verification of cell-specific deletion of ETAR on (A) FoxD1-stroma derived cells (FOX
D1Cre/+
- 
ETAR
fl/fl
); scale bar = 50 µm, ETAR, renin actin (B) vascular smooth muscle cells (SMMHC-Cre-ER
T2
- 
ETAR
fl/fl
 );scale bar = 10 µm;ETAR, renin actin  
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To investigate if further ETA-receptor expression locations have a crucial effect on the renin 
system in general, mice with conditional CAGG-Cre-ERT2 recombinase were paired with 
ETAR loxP animals in order to decrease ETAR expression under the control of β-actin 
promoter/enhancer coupled with the cytomegalovirus immediate-early enhancer. All CAGG-
Cre-ERT2-ETARfl/fl kidneys showed a reduction of ETA-receptor expression of 62 % after 3 
weeks of tamoxifen chow induction (Fig.17A) compared to controls (ETARfl/fl). In addition, 
IHC studies on kidney paraffin sections showed a decrease of ETAR expression widely 
distributed in the kidney compared to controls (Fig 17B).  
Moreover, all CAGG-Cre-ERT2- ETARfl/fl displayed normal developed renin positive JG cells 
as well as unchanged renin mRNA levels, PRC values and systolic blood pressure levels 
compared to controls (Fig.18A,B,C).  
Fig. 16: Characterization of ETA receptor 
isoform expressed on FOXD1 stroma derived 
cells and on vascular smooth muscle cells 
for renin synthesis and secretion (A) relative 
renin mRNA abundance, (B) plasma renin 
concentration (C) and blood pressure 
measurement via tail cuff method was not 
essentially changed in FOX
D1Cre/+
- ETAR
fl/fl
 and 
in SMMHC-Cre-ER
T2
-ETAR
fl/fl
 compared to 
controls; n=10 except bpm n=3 each group 
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Fig. 17: Verification of reduced expression of ETAR in the kidney due to conditional deletion (A) 
decline of ETAR expression after tamoxifen induction diet for 3 weeks of 62%; n= 8 each group; p= 0.0044 
(**) (B) IHC of CAGG-Cre-ER
T2
-ETAR
fl/fl
 kidney section, ETAR, renin actin,scale bar = 50 µm, ETAR 
expression staining with antibody was remarkably reduced on kidney sections 
Fig. 18: Characterization of ETA 
receptor isoform on the renin 
system in CAGG-Cre-ER
T2
-ETAR
fl/fl
 
(A) relative renin mRNA abundance, 
n=10 (B) plasma renin concentration, 
n=10 (C) blood pressure 
measurement via tail cuff method 
was unchanged in CAGG-Cre-ER
T2 
compared to controls; n=3 each 
group 
A B 
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3.2.4.2 The role of ET-1 after cell specific deletion of ETAR on the renin 
secretion in vitro 
After studying the direct effect of ET-1 through ETAR expressed on renin producing JG cells 
for the renin synthesis and secretion (3.2.3) it was necessary to examine potential indirect 
effects of ET-1/ETAR signaling pathway on RS in addition. All Cre+ strains mentioned and 
verified in 3.2.4 displayed in the isolated perfused kidney model an inhibition of renin 
secretion via ET-1 whereas it should be noted that differences occurred between groups with 
no essential changes compared to controls (Fig.19A). All groups resulted in an inhibition of 
nearly 80-90 % at 1 nM ET-1.The inhibition is mainly determined through a reduction of renal 
blood flow (Fig.17B; ~5 ml/g x min-1 or below at 1 nM ET-1) and not due to a changes in renin 
concentration (data not shown). All experiments were performed under same conditions with 
constant pressure and all animals had similar bodyweights (20 g – 25 g). After adding an 
increasing concentrations (10 pM, 30, 100, 300 pM and 1nM ) of ET-1 to the system, all 
groups showed a decrease in renin secretion rate. There was no significant change to the 
controls (ETARfl/fl).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 19: Isolated perfused kidneys of 
cell-specific animal models 
(FOX
D1Cre/+
- ETAR
fl/fl
, SMMHC-Cre-ER
T2
-
ETAR
fl/fl
, CAGG-Cre-ER
T2
-ETAR
fl/fl
) and 
controls (ETAR
fl/fl
) displayed an 
inhibition of (A) renin secretion via 
adding ET-1 in increasing concentrations 
over (B) renal blood flow declined due to 
ET-1; flow mainly mediates inhibition of 
renin secretion; iso = isoproterenol; 
experiment was performed on constant 
perfusion pressure 
A. 
B. 
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To summarize the first chapter of the present study, given results show no significant indices 
for a direct inhibiting effect of ET-1/ETAR signaling pathway on the level of renin positive 
cells for renin synthesis and secretion in vivo. In addition, all adult Ren1d+/Cre-ETARfl/fl animals 
showed normal developed renin positive JG cells, similar systolic blood pressure and PRC 
values as well as no essential change in renin mRNA abundance compared to controls. 
Moreover, first results suggest that the deletion of ETAR isoform on smooth muscle cells, 
stroma derived cells as well as the significant reduction of ETAR expression (SMMHC-Cre-
ERT2- ETARfl/fl, FOXD1Cre/+- ETARfl/fl, CAGG-Cre-ERT2-ETARflf) seem to have no essential 
effect on the renin mRNA abundance, systolic blood pressure values and PRC-levels. The 
renal ETA-receptor isoform is suggested to be of less relevance for renin synthesis and 
secretion in vivo and in vitro. 
 
3.3 Role of ETB-receptor isoform on renin synthesis and secretion in 
vivo  
3.3.1 Verification of renin cell-specific deletion of ETBR (Ren1d+/Cre-ETBRfl/fl) 
Previous shown results indicate that ETA-receptor isoform localized on renin producing cells 
has no essential direct effect on the level for renin and synthesis. The following chapter 
concentrates on the potential role of ETB receptor isoform located on renin producing cells 
for renin synthesis and secretion. It should be mentioned at this juncture ETBR mRNA signal 
could also be detected on renin producing cells as shown in 3.1. Therefore a renin cell-
specific ETBR animal model via Cre/loxP system (ETBR loxP animals with kindly permission 
of Miles L. Epstein from Department of Anatomy, School of medicine and Public Health, 
University of Wisconsin, Madison, USA) was generated. Mice which were genotyped as 
Ren1d+/Cre- ETBRfl/fl, were considered as knockout animals with a loss of ETBR exclusively on 
renin producing cells, whereas mice, analyzed as Ren1d+/+-ETBRfl/fl (or ETBRfl/fl) with no active 
Cre-recombinase were determined as control animals. The efficacy of ETBR deletion was 
verified by ETB-receptor in situ hybridization BaseScope® assay from ACD on adult kidney 
sections due to lack of working antibody. In control kidneys (ETBRfl/fl) ETB-receptor mRNA 
signal was found on vascular smooth muscle cells, endothelial cells, proximal tubular cells, 
collecting duct, mesangial cells, interstitial cells and renin producing JG cells (Table8 and 
Fig.9,10). In Ren1d+/Cre-ETBRfl/fl kidneys ETBR mRNA signal was lacking on renin producing 
cells only (Fig.20B) compared to ETBRfl/fl mice (Fig.20A).  
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3.3.2 Characterization of renal ETB-receptor isoform and its potential direct 
effect on renin synthesis and secretion in vivo 
In order to study a potential direct effect of ETBR pathway on the level of renin producing 
cells on the renin system, more precisely on renin synthesis and secretion in vivo, it was 
necessary to study relative renin mRNA abundance, plasma renin concentration as well as 
systolic blood pressure under basal conditions first.  
All Ren1d+/Cre- ETBRfl/fl animals showed unchanged relative renin mRNA abundance and 
plasma renin concentration compared to controls. In addition, Ren1d+/Cre-ETBRfl/fl mice had 
normal systolic blood pressure values (139.8 ±4.897) relative to ETBRfl/fl animals (134.8 ± 
1.001) (Fig.21) and normal developed juxtaglomerular renin positive cells after performing 
immunohistochemistry on kidney sections. These results indicate that ETB-receptor located 
on renin producing cells seems to be of less relevance for renin synthesis and secretion in 
vivo.  
 
 
 
 
Fig. 20: Verification of renin cell-specific deletion of ETBR via BaseScope® ISH assay with (A) kidney 
section of ETBR
fl/fl
 after chronic stimulation with low salt diet/enalapril intake for three weeks; ETBR mRNA 
signal with renin; scale bar = 10 µm (B) kidney section of Ren
1d+/Cre
-ETBR
fl/fl
 after chronic stimulation with low 
salt diet/enalapril intake for three weeks; ETBR mRNA signal lacked on renin producing cells only; renin; scale 
bar = 10 µm 
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In order to study if ETBR expressed on renin producing cells is directly involved on the 
regulation of the renin system, Ren1d+/Cre- ETBRfl/fl were treated with either a high salt (4 % 
NaCl ) or low salt (0.02 % NaCl) diet with ongoing enalapril intake for three weeks. (Fig.22). 
Feeding a low salt/enalapril diet increased renin mRNA abundance 16-fold and PRC 62-fold, 
without differences between controls and Ren1d+/Cre-ETBRfl/fl. However, feeding a high salt 
diet reduced renin mRNA abundance slightly in controls whereas renin levels were 
significantly decreased in Ren1d+/Cre-ETBRfl/fl mice compared to ETBRfl/fl after normal salt 
(p=0.0012) and high salt diet (p=0.006) (Fig.22A). Moreover, Ren1d+/Cre-ETBRfl/fl showed 
unchanged PRC-levels after high salt diet compared to controls (Fig.22B).  
 
Fig.21: Characterization of potential role 
of ETBR on renin system in vivo (A) 
relative renin mRNA abundance was 
unchanged compared to controls under basal 
conditions and (B) plasma renin 
concentration was unchanged in both 
models, n=5; (C) systolic blood pressure 
measurement was unchanged in both groups 
(ETBR
fl/fl
: 134.8 ± 1.001; Ren
1d+/Cre
-ETBR
fl/fl:
 
139.8 ±4.897); n=4 
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3.3.3 Role of ETB-receptor isoform on the renin cell lineage for renin secretion 
in vitro 
To further study the potential role of the ET-1/ETBR pathway on renin secretion, isolated 
perfused kidney experiments were performed in adult Ren1d+/Cre-ETBRfl/fl animals (2.2.3 and 
for protocol and setup). The renin cell-specific deletion of ETBR did not influence the 
inhibition of renin secretion through ET-1 (Fig.23). After adding ET-1 ( 30 pM, 100 pM, 300 
pM and 1 nM ET-1) in increasing concentrations to the ex situ system, Ren1d+/Cre-ETBRfl/fl 
kidneys displayed an inhibition of renin secretion. (Fig.23A) mainly mediated through a 
reduction of renal blood flow (ml/ g x min-1) as in controls (Fig.23B; <5 ml/min x g). All 
Fig. 22: Characterization of potential role of ETBR on the physiological control of the renin 
system in vivo (A) relative renin mRNA abundance was unchanged compared to controls under 
basal conditions and after 3 week of LSE in both genotype groups; relative renin mRNA levels were 
significantly decreased in Ren
1d+/Cre
-ETBR
fl/fl
 after high salt diet compared to NS-controls 
(p=0.0012) and HS-controls (p=0.006), n=5 (B) plasma renin concentration was unchanged in both 
models under basal conditions and after 3 week of LSE and HS relative renin mRNA levels were 
significantly increased after LSE (p<0.05); n=5; 
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A. 
B. 
experiments were performed under same condition with constant pressure and all animals 
had similar bodyweights (20 g – 25 g). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
With respect to results of the second chapter of present study, it can be concluded that there 
are no essential indices for a direct involvement of ETBR isoform located on the level of renin 
positive cells for renin synthesis or secretion and in addition on the physiological regulation of 
the renin system in vivo. Moreover, all adult Ren1d+/Cre-ETBRfl/fl animals showed normal 
developed renin positive JG cells, similar systolic blood pressure and PRC values as well as 
no essential change in renin mRNA abundance compared to controls. The inhibition of renin 
secretion in Ren1d+/Cre-ETBRfl/fl isolated perfused kidneys is primarily mediated by the renal 
blood flow as shown in Ren1d+/Cre-ETARfl/fl experiments (3.2.3). 
Fig. 23: Isolated perfused 
kidneys of Ren
1d+/Cre
-
ETBR
fl/fl
 and controls 
displayed an inhibition of 
(A) renin secretion via 
adding ET-1 in different 
concentrations (B) renal 
blood flow declined due to 
ET-1;flow mainly mediates 
inhibition of renin secretion; 
iso = isoproterenol; 
experiment was performed 
on constant perfusion 
pressure 
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3.4 Role of ETA and ETB-receptors on renin synthesis and secretion in 
vivo 
Previous shown results indicate that ETA- and ETB-receptor isoforms located on renin 
positive JG cells, are of less relevance for the physiological control of renin synthesis and 
secretion in vivo. In order to exclude possible ET-receptors interactions, it was necessary to 
further study a potential direct influence of both ET-receptors for renin synthesis and 
secretion in vivo.  
3.4.1 Verification of renin cell-specific deletion of both ET receptors (Ren1d+/Cre-
ETARfl/fl-ETBRfl/fl) 
In order to study the potential role of both ET-receptors on the level of renin producing cells 
for renin synthesis and secretion, it was necessary to generate a renin cell-specific ETAR 
and ETBR animal model via Cre/loxP system. Mice which were genotyped as Ren1d+/Cre-
ETBRfl/fl-ETARfl/fl, were considered as knockout animals with a loss of ETAR and ETBR 
exclusively on renin producing cells. Whereas mice, analyzed as Ren1d+/+-ETBRfl/fl-ETARfl/fl 
(or ETBRfl/fl-ETARfl/fl) with no active Cre-recombinase were determined as control animals. 
The efficacy of ETAR and ETBR deletion was verified by either ETAR immunohistochemistry 
(Fig.24A) or ETB-receptor in situ hybridization BaseScope® assay from ACD (Fig.24B) on 
adult kidney sections. In control kidneys both receptors were present on renin producing JG 
cells. 
 
Fig. 24: Verification of renin cell-specific deletion of (A) ETAR and (B) ETBR of Ren
1d+/Cre
-ETAR
fl/fl
-
ETBR
fl/fl
; (A) IHC with ETAR, renin ,scale bar = 20 µm; ETAR lacked exclusively on rpcs of Ren
1d+/Cre
-ETAR
fl/fl
-
ETBR
fl/fl
 (B) ETBR BASEscope® assay of Ren
1d+/Cre
-ETAR
fl/fl
-ETBR
fl/fl 
with additional IHC with renin; scale bar 
= 20 µm; ETBR lacked on rpcs of Ren
1d+/Cre
-ETAR
fl/fl
-ETBR
fl/fl
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3.4.2 Investigations to study a potential direct effect of ETA and ETB receptors 
expressed on renin producing juxtaglomerular cells for renin synthesis and 
secretion in vivo and in vitro 
After verification of ETA- and ETB-receptor renin cell-specific knockout animal model with in 
situ hybridization BASEscope® from ACD and IHC (Fig.24), it was necessary to study the 
potential effect on the renin system further. Mice which were genotyped as Ren1d+/Cre-
ETARfl/fl-ETBRfl/fl were considered as knockout animals with a complete loss of ET-receptors 
on renin producing cells. Whereas mice, analyzed as Ren1d+/+-ETARfl/fl-ETBRfl/fl (or ETARfl/fl-
ETBRfl/fl) with no active Cre-recombinase were determined as control animals. All Ren1d+/Cre-
ETARfl/fl-ETBRfl/fl animals displayed normal renin mRNA abundance (Fig.25A) and normal 
systolic blood pressure values (Fig.25C) as in controls under basal conditions. In addition, 
plasma renin concentration levels were reduced in Ren1d+/Cre-ETARfl/fl-ETBRfl/fl animals 
compared to control littermates (Fig.25B) but showed no significant difference in both groups. 
All in vivo experiments were performed with adult mice only. Histological staining on kidney 
sections revealed normal developed renin positive cells at the juxtaglomerular cell apparatus 
in the kidney (Fig.24). 
 
 
 
 
 
 
 
 
 
A. 
Fig. 25: Characterization of potential effect of 
both ET receptors on the renin synthesis and 
secretion (A) relative renin mRNA abundance 
was unchanged in Ren
1d+/Cre
-ETAR
fl/fl
-ETBR
fl/fl
 
compared to controls (ETAR
fl/fl
-ETBR
fl/fl
),(B) 
plasma renin concentration was not significantly 
changed in Ren
1d+/Cre
-ETAR
fl/fl
-ETBR
fl/fl
 
compared to controls (C) no difference in systolic 
blood pressure values of both groups; (A),(B) 
n=6 each group; (C) n=3 for controls, n=4 for 
“double knockout” 
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A.
.. 
B. 
In order to study the potential role of ET-1/ET-receptors pathway on renin secretion further, 
isolated perfused kidney was performed in adult Ren1d+/Cre-ETARfl/fl-ETBRfl/fl mice (2.2.3 for 
protocol and setup). The renin cell-specific deletion of both ET-receptors did not influence the 
inhibition of renin secretion through ET-1 (Fig.26). After adding ET-1 (30 pM, 100 pM, 300 
pM and 1 nM ET-1) in increasing concentrations to the ex situ system, Ren1d+/Cre-ETARfl/fl-
ETBRfl/fl kidneys displayed an inhibition of renin secretion (Fig.26A) mainly mediated through 
a reduction of renal blood flow (ml/g x min-1) (Fig.26B) as in controls. All experiments were 
performed under same condition with constant pressure and all animals had similar body 
weights (20 g – 25 g). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 26: Isolated perfused kidneys of Ren
1d+/Cre
-ETAR
fl/fl
-ETBR
fl/fl
 and controls displayed an 
inhibition of (A) renin secretion via adding ET-1 in different concentrations over (B) renal blood 
flow decline due to ET-1;flow mainly mediates  inhibition of renin secretion; iso=isoproterenol; 
experiment was performed on constant perfusion pressure 
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Fig. 27: Verification of stroma derived cell-specific deletion of ETAR in FOX
D1Cre/+
- ETAR
fl/fl
-
ETBR
fl/fl
 (A) WT kidney section, IHC with ETAR, renin and α-sma, scale bar = 10 µm, ETAR was 
expressed on rpcs, smooth muscle cells and mesangial cells (stroma derived cells) of ETAR
fl/fl
-
ETBR
fl/fl
 (B) IHC of FOX
D1Cre/+
- ETAR
fl/fl
-ETBR
fl/fl
 kidney section with ETAR, renin and α-sma scale bar 
= 20 µm; ETAR lacked on rpcs, smooth muscle cells and mesangial cells 
 
Thus, the results of present chapter suggests, that renin cell-specific deletion of both ET 
receptors has no significant direct effect on renin synthesis and secretion, moreover on the 
renin system in vivo and in vitro.  
3.4.3 Characterization of renal ETA- and ETB-receptors expressed on stroma 
derived cells on renin synthesis and secretion in vivo and in vitro 
Previous shown results indicate that the crucial role of ET-receptors expressed on renin 
producing cells seems to be of less relevance for the renin synthesis and secretion in vivo. In 
addition, neither ETA-receptor nor ETB-receptor isoform expressed on stroma derived cells 
seem to have no effect on the renin system. Further experiments should investigate if there 
is an effect of both ET receptors based on stroma derived cells on the renin synthesis and 
secretion. 
Therefore it was necessary to generate an ET-receptor stroma derived cell-specific “double 
knockout” animal model (FOXD1Cre/+- ETARfl/fl-ETBRfl/fl). The efficacy of deletion was verified 
by IHC for ETAR (Fig. 27) and ISH BASEscope® assay for ETBR (Fig.28). In FOXD1Cre/+- 
ETARfl/fl-ETBRfl/fl animals, both ET-receptors expression lacked exclusively on renin 
producing cells, mesangial cells, vascular smooth muscle cells as well as interstitial cells.  
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Fig. 28: Verification of stroma derived cell-specific deletion of ETBR in FOX
D1Cre/+
- ETAR
fl/fl
-
ETBR
fl/fl
 with ISH BaseScope® assay and IHC (A) WT (ETAR
fl/fl
-ETBR
fl/fl
) kidney section, ISH with 
ETBR and additional IHC with renin, ETBR is expressed on rpcs (B) in FOX
D1Cre/+
- ETAR
fl/fl
-ETBR
fl/fl
 
kidneys ETBR lacks on renin producing cells, ISH BaseScope with IHC renin (C) WT kidney section, 
ISH and IHC with α-sma, ETBR is expressed on smooth muscle cells (D) in FOX
D1Cre/+
- ETAR
fl/fl
-
ETBR
fl/fl
 kidneys ETBR lacks on smooth muscle cells, ISH with IHC with α-sma, (E) WT kidney 
section, ISH with EBTR and α-integrin-8, ETBR is epressed on mesangial cells (F) in FOX
D1Cre/+
- 
ETAR
fl/fl
-ETBR
fl/fl
 kidneys ETBR lacks on mesangial cells, ISH with IHC α-integrin-8, (A)-(F) scale bar 
=  5 µm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
77 
 
Fig. 29: Characterization of potential 
indirect kidney effect of both ET receptors 
on renin synthesis and secretion in vivo 
(A) relative renin mRNA abundance was not 
significantly changed in FOX
D1Cre/+
- ETAR
fl/fl
-
ETBR
fl/fl
 compared to controls (ETAR
fl/fl
-
ETBR
fl/fl
) n=4,(B) plasma renin concentration 
was not significantly changed in FOX
D1Cre/+
- 
ETAR
fl/fl
-ETBR
fl/fl
 compared to controls n=2  
(C) no difference in systolic blood pressure 
values of FOX
D1Cre/+
- ETAR
fl/fl
-ETBR
fl/fl
 (n=2) 
compared to controls n=3 
In order to study a potential stroma derived cell-specific indirect effect of renal ET-receptors 
on the renin system more precisely on renin synthesis and secretion in vivo, it was necessary 
to study relative renin mRNA abundance, plasma renin concentration as well as systolic 
blood pressure under basal conditions prospectively after verification of deletion. 
All FOXD1Cre/+- ETARfl/fl-ETBRfl/fl animals showed no significant difference in relative renin 
mRNA abundance and plasma renin concentration compared to controls under basal 
conditions (Fig.29). PRC level were slightly diminished in FOXD1Cre/+- ETARfl/fl-ETBRfl/fl 
compared to controls (ETARfl/fl-ETBRfl/fl) In addition, FOXD1Cre/+- ETARfl/fl-ETBRfl/fl mice had 
normal systolic blood pressure values (128.5 ±1.109) relative to ETARfl/fl-ETBRfl/fl control 
littermates (130 ± 1.048) (Fig.29) and as shown in Fig.27/28 normal developed 
juxtaglomerular renin positive cells after performing immunohistochemistry and in situ 
hybridization (BASEScope® assay) on kidney sections. These results indicate that both ET 
receptors expressed on stroma derived cells in the kidney seem to be of less relevance for 
renin synthesis and secretion in vivo. 
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B. 
A.
. 
In the isolated perfused kidney (setup and protocol 2.2.3) all FOXD1Cre/+-ETBRfl/fl and 
FOXD1Cre/+-ETARfl/fl displayed an inhibition of renin secretion mainly mediated by the decline 
of renal blood flow via ET-1. However renin secretion did not show an inhibition in FOXD1Cre/+- 
ETARfl/fl-ETBRfl/fl through ET-1 (Fig 30A). Moreover, in FOXD1Cre/+-ETARfl/fl renin secretion 
showed inhibition down to 60 % whereas FOXD1Cre/+-ETBRfl/fl isolated kidneys declined down 
to 92 %.  
The effect of FOXD1Cre/+-ETBRfl/fl and FOXD1Cre/+-ETBRfl/fl was mainly mediated by a reduction 
of the renal blood flow (<5 ml/g x min-1) whereas decline of renal blood flow in FOXD1Cre/+- 
ETARfl/fl-ETBRfl/fl was attenuated rapidly (20 ml/g x min-1) by 10 pM ET-1 to 14 ml/g x min-1 by 
1 nM ET-1 ) (Fig.30B). The renal blood flow of FOXD1Cre/+- ETARfl/fl-ETBRfl/fl was nearly in a 
steady state compared to ET-receptor isoform knockout kidneys. In summary, the deletion of 
both ET-receptors in stroma derived cells did not inhibit renin secretion compared to single 
receptor isoform deletion whereas it seems not to be mediated by a decline of the renal 
blood flow because the flow could be detected nearly in a steady state in FOXD1Cre/+- ETARfl/fl-
ETBRfl/fl. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.30: Isolated perfused 
kidneys of FOX
D1Cre/+
- ETAR
fl/fl
-
ETBR
fl/fl
 , FOX
D1Cre/+
-ETAR
fl/fl
 
FOX
D1Cre/+
-ETBR
fl/fl
 (A) renin 
secretion was inhibited through 
ET-1 in FOX
D1Cre/+
-ETBR
fl/fl
 and 
FOX
D1Cre/+
-ETAR
fl/fl
; whereas in  
FOX
D1Cre/+
- ETAR
fl/fl
-ETBR
fl/fl
 
isolated kidneys showed no 
inhibition of renin secretion after 
ET-1 (B) renal blood flow was 
reduced in FOX
D1Cre/+
-ETBR
fl/fl
 
and FOX
D1Cre/+
-ETAR
fl/fl
 through 
ET-1 but decline was attenuated 
in FOX
D1Cre/+
- ETAR
fl/fl
-ETBR
fl/fl
; 
iso=isoproterenol; experiment 
was performed on constant 
perfusion pressure n= 2 each 
group 
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4 Discussion 
Renin is the central regulatory factor of the Renin-Angiotensin-Aldosterone system. It is 
mainly synthesized in the kidney from juxtaglomerular epitheloid cells and is stored in 
secretory vesicles until release. The release of renin is stimulated by cAMP signaling 
pathway and inhibited by an increase in cytosolic Ca2+ concentration. Renin synthesis and its 
release from JG cells are regulated by various local and systemic factors. Several 
vasoconstrictor hormones such as ANG II and arginine vasopressin have been shown to 
inhibit renin release from juxtaglomerular cells. In addition, different in vitro studies and one 
in vivo study on dogs have suggested endothelins as negative regulators of renin expression 
and secretion (Berthold et al., 1999; Scholz et al., 1995; Ritthaler et al., 1995; Ritthaler et al., 
1996). The endothelin system consists of three peptide hormones Endothelin-1, Endothelin-2 
and Endothelin-3 and their G-protein coupled receptors Endothelin-A and Endothelin-B 
receptor. Previous studies displayed Endothelin-1 as a potent vasoconstrictor in the renal 
vascular system and as an inhibitor of the synthesis and secretion of renin from 
juxtaglomerular epitheloid cells in vitro whereas ETAR is suggested to act as the main 
receptor (Kaasjager et al., 1997; Bohm et al., 2003). The work at hand aimed to examine the 
relevance of endothelins focusing on ET-1/ETA-receptor and/or ETB-receptor signaling 
pathway for the physiological regulation of renin synthesis and secretion in vivo. Moreover, 
we tried to investigate if the proven inhibiting effect on the renin system via ETAR and/or 
ETBR signaling pathway is accompanied by a direct effect on the level of renin producing 
juxtaglomerular cells in the kidney or if the effect of renal ET receptors on the renin system is 
systemic, general or regulated by ET receptors expressed on stroma derived cells in the 
kidney.  
4.1 ET-receptor localization in the adult murine kidney 
It was inevitable to study the expression pattern of both receptors in the adult murine kidney 
first. The ETA- and ETB-receptor isoforms were localized on mouse kidney sections with co-
localization (IHC, ISH) analysis on renin producing JG cells for present study. Moreover, both 
ET-receptors are suggested as general markers for renin producing cells because they could 
be located on recruited, ectopic expressed and fetal renin producing cells, too.  
In addition, both receptors could be detected on smooth muscle cells, but only ETBR 
expression was found on endothelial cells of vascular structures. Similar results could be 
demonstrated by Wendel et al. in the rat kidney, whereas they noted, a weak immunostaining 
for ETB receptor on endothelial cells (Kohan et al., 2011a; Wendel et al., 2006).The ETA 
receptor could also be detected on collecting duct cells, mesangial cells and distal tubular 
structures showing no signal on podocytes and proximal tubular structures whereby Garvin 
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and Sanders and Wendel et. al. published similar results using rats in their experimental 
approaches (Garvin and Sanders, 1991; Wendel et al., 2006). With the help of ISH 
technique, expression of ETB-receptor mRNA signal was detected further on interstitial cells, 
mesangial cells, proximal tubular cells and collecting duct cells (cortical and medullary) which 
was also shown by Wendel et al. whereas their study did not focus on ETBR expression in 
renal interstitial cells (Wendel et al., 2006). 
It has been shown, that ETA and ETB receptors are widely expressed in the kidney and 
some specific cells are able to express both receptor isoforms (Kohan et al., 2011b). Taken 
together, both ET-receptor isoforms are co-expressed on renin producing cells, smooth 
muscle cells, mesangial cells, distal tubular structures and collecting duct cells. The renal 
ETBR is suggested as the predominant isoform in the kidney (Kedzierski and Yanagisawa 
2001) which could be affirmed in present thesis. 
Endothelin receptors are known to be present on plasma membrane of each cell where ETs 
can bind to its receptors causing a variety of different but often similar biological effects 
based on various signaling cascades, including cyclooxygenases, cytochrome P-450, nitric 
oxide synthase and adenylyl cyclases and others (Kohan et al., 2011b; Sorokin and Kohan, 
2003; Kohan, 2010). It should also be mentioned that the relative expression pattern of both 
receptors differs between animal models and humans, possibly reflecting regional 
differences within the kidney (Kohan et al., 2011b). With respect to present findings, all 
experiments were performed with adult mice.  
4.2 The ET receptor isoforms and its potential role on the renin synthesis 
and secretion in vivo 
Focusing on the localization of both ET receptors on renin producing JG cells to study a 
potential role on the renin system it was necessary to generate a renin cell-specific model in 
which either ETA- (Ren1d+/Cre- ETARfl/fl) or ETB-receptor (Ren1d+/Cre- ETBRfl/fl ) isoform was 
deleted. The efficacy of deletion was determined by IHC or ISH technique, whereby in all 
Cre+ kidney sections ET-receptor immunoreactivity or mRNA detection signal was lacking on 
renin producing cells only. Therefore all used Cre+-models were distinct to study the role of 
ET receptors further.  
4.2.1 The potential role of ETAR located on the renin cell lineage for renin 
synthesis and secretion in vivo 
Besides all three peptides, ET-1 is the most potent and has been shown to primarily act as a 
vasoconstrictor via ETA-receptor in the kidney (Kaasjager et al., 1997; Bohm et al., 2003; 
Maguire and Davenport 2011). In addition, in vitro studies have shown that ET-1 is able to 
inhibit renin release from juxtaglomerular cells through a Ca2+ dependent mechanism 
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(Matsumura et al., 1989; Rakugi et al., 1988; Takagi et al., 1988; Kohan et al., 2011b). The 
ETAR expressed in the kidney has been shown to play a crucial role in a variety of renal 
physiological and pathological functions in vivo, whereas its role, primarily through ET-1, 
focusing on the level of renin producing cells and the potential direct effects on the renin 
synthesis and exocytosis are still unknown.  
Ren1d+/Cre-ETARfl/fl animals showed normal renin mRNA levels, PRC values and normal 
systolic blood pressure compared to controls (ETARfl/fl). In addition, all animals developed 
normal renin producing JG cells as in controls. During nephrogenesis renin producing cells 
have been shown to originate from the metanephric mesenchyme and accumulate 
afterwards at the vascular wall (Sequeira Lopez et al., 2001). Although, we could detect 
ETAR on mesenchymal renin producing cells during kidney development (data not shown), 
the receptor seems to be not of major relevance for the development of renin producing cells.  
During further procedure one tried to understand the potential role of ETAR on the 
physiological regulation of the renin system. Ren1d+/Cre- ETARfl/fl mice displayed after a low 
salt/enalapril diet a significant increase in renin mRNA levels and PRC with no change to 
controls. Conversely, feeding high salt diet lowered renin mRNA abundance and PRC 
values, again without difference between the two genotypes. Although, renin producing cells 
and recruited renin positive cells of the kidney express ETAR isoform, it appears not to be of 
major relevance for the physiological regulation of renin synthesis by the rate of salt intake.  
The isolated perfused kidney of Ren1d+/Cre- ETARfl/fl displayed an inhibition of renin secretion 
after ET-1 was given to the ex situ system in increasing concentrations, whereas this effect is 
mainly mediated through a reduction of the renal blood flow. These results indicate that the 
ETA receptor isoform located on renin producing cells has no essential direct effect on the 
inhibition of renin secretion and synthesis. 
It should be noted, that the main concept concerning renal ET biology is based on the 
context of local microenvironment (Schneider et al., 2007; Kohan et al., 2011b). ET receptors 
localized in different parts within the kidney are meant to show opposing actions, e.g. in the 
vasculature, where ETAR activation causes primarily vasoconstriction whereas ETBR 
activation causes, at least initially, vasodilatation mediated by nitric oxide (NO) produced 
from endothelial cells (Kohan et al., 2011b). However it has also been shown, that ETB 
shows vasoconstrictive effects mediated on vascular smooth muscle cells (Schneider et al., 
2007) primarily on afferent arterioles whereas ETBR provide a vasodilatory influence on 
normal efferent arterial vascular tone (Kohan et al., 2011b). In addition, under normal 
conditions i.e. low concentrations of ET-1 most of the vasoconstriction is ETA-dependent. 
However it has been shown after additional infusion of ET-1 in rats that ETA-independent 
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vasoconstriction was present (Pollock and Opgenorth, 1993, 1994b; Kohan et al., 2011a, 
2011b), suggesting these results rather promote ETB-mediated actions in situations where 
concentration of ET-1 is strongly increased (e.g. chronic salt diet, renal fibrosis). 
With respect to present deletion of ETAR on renin cells, our results rather promote theory of 
potential compensational effects of ETB-receptor and possible ET-receptor interaction. 
Besides binding to ETAR, ET-1 has also been investigated to display vasoconstrictor effects 
through binding to ETBR (Davenport, 2002) showing a potential compensatory mechanism 
equilibrating physiological homeostasis. In addition, the treatment of selective ETAR 
antagonist BQ-123 did not change arterial blood pressure as well (Kaasjager 1997, Maguire 
Davenport 2015). In the last few years, several studies promote a potential ETA-ETB 
receptor crosstalk in the mediation of responses to ET-1 (Rapoport and Zuccarello, 2011; 
Harada et al., 2002). For example, ETB receptors in the anterior pituitary gland appeared to 
bind only ET-1 during blockade of ETA receptors in vitro (Harada et al., 2002; Schneider et 
al., 2007). 
These results seem to support the theory, that both receptors are able to function in a similar 
manner depending on which receptor is activated (Harada et al., 2002). 
If expression of ETAR is declined or the activation is somehow ceased on renin producing 
cells, ET-1 appears to bind primarily on ETBR. There are several findings in the work at hand 
which support hypothesis of ETBR activation while ETA receptor isoform expression is 
decreased in different renal cells. All used Ren1d+/Cre- ETARfl/fl and FOXD1Cre/+-ETARfl/fl kidneys 
displayed for instance an increase in ETBR mRNA abundance compared to control animals 
(data not shown).  
With respect to present findings in the isolated perfused kidney model, the inhibition of renin 
secretion via ET-1 is not essential mediated via ETAR isoform but rather ETB-receptor 
seems to be able to compensate present deletion or “inactivation” of ETAR on renin 
producing JG cells while displaying similar vasoconstrictive effects as in controls. To support 
or exclude this hypothesis it was necessary to generate further an ETBR renin cell-specific 
animal model and in addition an ETAR and ETBR double knockout renin cell-specific animal 
model. 
However it should be concluded at this juncture that the role of ETA receptor isoform 
expressed on renin producing JG cells due to present findings is of less relevance for the 
physiological regulation of renin synthesis and secretion in vivo and seems to become more 
relevant in terms of pathophysiology.  
Discussion 
83 
 
Recent studies suggest that the ET system, i.e. ETAR, plays an active role in progression of 
renal failure (Kedzierski and Yanagisawa, 2001). Several ETAR antagonist administration 
studies support this hypothesis. The usage of BQ-123 in rats with acute renal failure 
improved for example glomerular filtration rate (GFR) and net tubular reabsorption, two 
important parameters for kidney function (Chan et al., 1994). In addition, treatment with 
FR139317 in partially nephrectomized rats lowered proteinuria and prolonged animal survival 
(Benigni et al., 1993). 
4.2.2 The potential role of ETBR located on the renin cell lineage for renin 
synthesis and secretion in vivo 
As mentioned above, ETBR has similar affinities for all three endothelin peptides (Davenport, 
2002) and has been shown to display crucial interplays regarding renal function (Kohan et 
al., 2011a, Kohan et al., 2011b) e.g. the role in renal sodium excretion, vasopressin 
regulation and acid base status (Ohuchi et al., 1999; Gariepy et al., 1998; Edwards et al., 
1993). However, its potential role on renin producing cells for renin synthesis and secretion in 
vivo has yet to be resolved. 
All Ren1d+/Cre- ETBRfl/fl kidneys showed normal renin mRNA and PRC levels under basal 
conditions. Moreover, animal kidney sections displayed normal developed renin cells at the 
juxtaglomerular cell apparatus with ISH assay and had normal systolic blood pressure 
compared to controls. These results indicate that ETB receptor isoform expressed on renin 
positive cells is suggested to mediate rather no crucial direct effect on the renin synthesis 
and secretion. Moreover, experiments with Ren1d+/Cre- ETBRfl/fl kidneys in isolated perfused 
kidney model reveal an inhibition of renin secretion while adding ET-1 in increasing 
concentrations whereas effect is primarily dependent on the decline of the renal blood flow 
suggesting rather ETA-mediated constrictor effects through ET-1.  
Compare to investigations discussed in 4.2.1, both groups (Ren1d+/Cre- ETARfl/fl, Ren1d+/Cre- 
ETBRfl/fl) displayed similar results regarding effects on renin system compared to control 
littermates regardless of which receptor isoform is deleted on renin JG cells. These results 
promote hypothesis that both receptor isoforms can show similar biological function (Kohan, 
2010; Kohan et al., 2011a) and in addition, they support theory mentioned above of potential 
ETA-ETB receptor cross talk (Kohan et al., 2011b; Kohan et al., 2011a; Yoon et al., 2016)   
Under basal conditions ETBR is suggested to mediate vasodilatation by the release of 
endothelin derived factors (NO, prostacyclin and/or endothelium-derived hyperpolarizing 
factor) acting as a feedback mechanism to limit the vasoconstrictive effect of ET-1 (Maguire 
and Davenport, 2015).  
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Regarding the role of ETB receptor on the physiological regulation of the renin system, 
Ren1d+/Cre- ETBRfl/fl mice showed a significant increase in renin mRNA abundance and PRC 
with no change to control animals after a low salt/enalapril diet. In contrast, feeding high salt 
lowered renin mRNA significantly compared to controls. With respect to present deletion of 
ETBR on renin cells, ET-1 seems to solely bind to ETAR rather promoting the inhibition of 
renin secretion and synthesis in vivo, as already concluded in vitro (Scholz et al., 1995; 
Ritthaler et al., 1995; Ritthaler et al., 1996).  
In theory, it is suggested that renin release is inhibited by high Na+-intake due to high renal 
ET-1 production, whereas Na+-transport mechanisms are inhibited in the proximal tubules, 
thick ascending limb and collecting duct cells in order to reduce Na+ reabsorption (Kohan et 
al., 2011a). Johnston et al., could determine ET-1 as a crucial regulator of sodium balance by 
promoting natriuresis through ETB-receptor in response to chronic salt intake (Johnston et 
al., 2016). Activated renal ETBR appears to promote these effects, at least in the medulla, 
via NO release (Plato et al., 2000; Jesus Ferreira and Bailly, 1997; Schneider et al., 2007). 
Moreover, our results showed high renal ET-1 expression in control kidneys after a low salt 
diet with ongoing enalapril intake as well as increased expression of ETBR (data not shown) 
in contrast ET-1 and ETBR production was unaffected by high salt diet (data not shown). 
Therefore, present results rather indicate an ETB-receptor mediated regulation during low 
salt diet whereas the involvement of ETB-receptor isoform during a high salt diet seems to be 
not of major relevance in vivo. 
Concentrating on the inhibition of renin release regulated by Ca2+-dependent mechanism, it 
should be noted that ET-1 maybe also potent for reducing renin release stimulated by 
different factors such as isoproterenol or cAMP (Kurtz et al., 1991; Moe et al., 1991; Kohan 
et al., 2011a), most likely via ETBR-dependent NO release (Ackermann et al., 1995; Ritthaler 
et al., 1995; Scholz et al., 1995; Kohan et al., 2011a, 2011b). However, the physiological 
connection between ET-1 and NO to control renin release need to be clarified first because 
opposing roles proposed for NO have been published. NO has been demonstrated to directly 
stimulate the release of renin from isolated JG preparations, although NO-dependent 
vascular relaxation can increase the pressure reaching the glomerulus, which would inhibit 
the exocytosis of renin through the intrarenal baroreceptor (Schweda et al., 2007; Kohan et 
al., 2011a, 2011b) whereas the inhibition of NO synthase reduces renin release in isolated 
afferent arterioles (Tharaux et al., 1997) 
With respect to present findings, ETB receptor isoform located on renin producing cells 
seems to be of less relevance for the physiological regulation of the renin system moreover 
for renin synthesis and secretion. The ETBR is suggested to be of crucial relevance for 
additional renal parameters mentioned above located on other renal cells. In contrast, in 
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order to examine, if the effect of ET-receptor isoform and the combination of both ET-
receptors for renin synthesis and secretion is based on systemic factors or stroma derived 
cells, additional experiments were performed. 
4.2.3 The potential indirect effects of ETA and ETB-receptor on renin synthesis 
and secretion in vivo 
Besides renin producing cells, both ET receptors are widely expressed in the kidney. After 
IHC and ISH co-localization analyzing studies, both ET-receptors could be determined on 
renin JG-cells indicating the functional role of each specific isoform seem to have no 
essential direct role for renin synthesis and secretion in vivo. Therefore, it was inevitable to 
further characterize potential indirect effects of renal ETA or ETB receptor isoforms 
expressed on additional renal cells than the renin cell lineage on the renin system in vivo.  
As mentioned in 4.1 renal ETA-receptor could be additionally localized on vascular smooth 
muscle cells, mesangial cells, collecting duct and distal tubular structures. Therefore different 
animal models were generated, where ETAR was cell-specific deleted in order to examine if 
the functional role on RAAS is regulated by ETAR expression on stroma derived cells or if 
the effect is systemic (FOXD1Cre/+-ETARfl/fl , SMMHC-Cre-ERT2-ETARfl/fl). Moreover, in order to 
characterize the general role of ETAR expression for renin synthesis and secretion, ETAR 
loxP animals were paired with conditional knockout CAGG-Cre-ERT2 animals (CAGG-Cre-
ERT2-ETARfl/fl). After activation of Cre recombinase through induction with tamoxifen chow for 
three weeks, ETAR expression was significantly decreased in the kidney down to 38 % 
compared to controls. The efficacy of each single deletion (FOXD1Cre/+-ETARfl/fl, SMMHC-Cre-
ERT2-ETARfl/fl, CAGG-Cre-ERT2-ETARfl/fl) was verified by IHC staining whereby ETAR 
exclusively lacked on specific cell types only.  
After in vivo investigation studies, all Cre+ animals mentioned above showed normal 
developed renin positive JG cells, renin mRNA abundance, PRC levels and systolic blood 
pressure values compared to controls. Only in CAGG-Cre-ERT2-ETARfl/fl mice renin mRNA 
abundance was slightly diminished. However these results indicate that general renal ETA 
receptor isoform seems to be of less relevance for renin synthesis and secretion. Moreover, 
it should be mentioned that induced CAGG-Cre-ERT2-ETARfl/fl mice showed no specific 
phenotype, had the ability of fertility and developed apparently completely normal. In 
contrast, different studies postulated that general deletion of either ETA-receptor isoform or 
ET-1 knockout mice were neonatal lethal due to developmental defects in cardiac and 
craniofacial structures (Clouthier et al., 1998; Kurihara et al., 1994) rather promoting that 
both ETAR and ET-1 are crucial for embryonic development whereas the inducible decline of 
receptor isoform expression showed no severe phenotype in the adulthood. In addition, 
general ETBR knockout mice die before adulthood because they develop aganglionic 
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megacolon and white spotting on the coat suggesting ETBR signaling is crucial for 
generating enteric neurons and melanocytes (Akashi et al., 2016; Baynash et al., 1994). 
In addition, isolated perfused kidney experiments were performed with all Cre+-genotypes, 
resulting in an inhibition of renin secretion after adding ET-1 to the ex situ system as shown 
in control littermates. It should be noted that the inhibition is primarily mediated by the 
reduction of the renal blood flow and not by an alteration of the renin concentration. With 
respect to present renal ETA receptor isoform deletion in different cell types, one can 
suggest that ETB-mediated effects are responsible for displaying mentioned results. It should 
be noted, that all Cre+ animal models showed increased ETBR mRNA abundance compare 
to controls supporting present hypothesis (data not shown).  
Focusing on ET receptors on smooth muscle cells, ETA receptor has been shown to be 
mainly expressed on those cells (Davenport and Maguire, 2011), which support present 
findings. However, recent studies confirm that the usage of ETAR-selective antagonists fully 
block these vasoconstrictor responses (Davenport and Maguire, 2011), which could not be 
confirmed in present thesis. All used SMMHC-Cre-ERT2-ETARfl/fl, and in addition all 
FOXD1Cre/+-ETARfl/fl as well as CAGG-Cre-ERT2-ETARfl/fl animals displayed an inhibition of 
renin secretion in the isolated perfused kidney through ET-1 and therefore suggesting ETB-
mediated vasoconstrictor effects. 
It has been shown that ET-1 via ETB-receptor is able to demonstrate vasoconstriction in the 
vascular system (Maguire and Davenport, 2015) especially in the afferent arteriole (Kohan et 
al., 2011a). Moreover, in humans, results of ET-1 infusion in the brachial artery show at low 
concentration an ETB-mediated vasodilatation. However, as the concentration increases to 
higher pathological concentrations, vasodilatation is overwhelmed by ETAR-mediated 
constrictor responses or involve non-ETAR receptor mediation (Maguire and Davenport, 
2015; Pollock and Opgenorth, 1994a). If ETAR expression is deleted on vascular smooth 
muscle cells, it is suggested, that our findings perchance support theory of ETB-mediated 
vasoconstrictor effect and hypothesis of ETA-ETB receptor cross link.  
Similar results were determined in SMMHC-Cre-ERT2-ETBRfl/fl (data not shown) and 
FOXD1Cre/+-ETBRfl/fl animals in the isolated perfused kidney model. As mentioned in 4.1 ETB-
receptor isoform is additionally expressed on interstitial cells, mesangial cells and vascular 
smooth muscle cells. All Cre+ animals displayed an inhibition of renin secretion via ET-1 
mainly mediated by renal blood flow. Therefore, it is rather ETAR-mediated vasoconstrictor 
effects through ET-1 during present ETBR-isoform deletion.  
In summary these results support theory that each receptor isoform seems to be able to 
compensate function of the other receptor isoform. Therefore, ETA and ETB-receptor 
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isoforms expressed in the kidney seem to have solely no indirect effect on the renin system 
and to be of less relevance for the physiological regulation of renin synthesis and secretion. 
The deletion of each single receptor is suggested to be compensated by the other receptor 
isoform to maintain physiological homeostasis. Both receptors’ function in terms of 
pathophysiology is suggested to be of more importance.  
4.3 The role of both ET-receptors expressed on the renin cell lineage for 
renin synthesis and secretion in vivo 
Expression of a single ET-receptor isoform on renin producing JG cells seems apparently not 
to be involved in mediating renin synthesis or secretion. In order to characterize potential 
compensational receptor effects or possible ET receptor interaction, it was necessary to 
further study the functional role of both ET receptors expressed on renin positive cells via 
ET-1. Although a great number of pharmacological agents have been used to analyze ET 
receptor isoform function, recent studies suggest an ET-receptor dimerization leading to 
substantial uncertainty about single receptor function (Boesen, 2008; Kohan et al., 2011a; 
Schneider et al., 2007).  
Perhaps characterization of single ET receptor function in the field of endothelin system is 
limited because in vitro studies showed ET receptors are able to form homo- and 
heterodimers (Gregan et al., 2004a; Gregan et al., 2004b) suggesting the process is 
regulated by a PDZ finger (Evans and Walker, 2008). Evans et al., could demonstrate that 
mutation of PDZ domain leads to delayed ET receptor internalization and prolonged increase 
in intracellular Ca2+-concentration in response to ET-1, suggesting that ET receptor 
heterodimerization affects receptor function (Evans and Walker, 2008; Kohan et al., 2011a). 
In order to investigate potential effects of receptor dimers on ET receptor isoform function on 
the renin system and to exclude potential compensational effects of ET receptor isoforms, it 
was inevitable to generate an animal model where ETA- and ETB-receptor are both deleted 
exclusively on renin producing cells (Ren1d+/Cre-ETARfl/fl-ETBRfl/fl). 
All Ren1d+/Cre-ETARfl/fl-ETBRfl/fl animals showed normal renin mRNA abundance and 
unchanged systolic blood pressure values compared to control littermates. Only PRC levels 
were slightly diminished in Ren1d+/Cre-ETARfl/fl-ETBRfl/fl as in controls. These results were 
surprising because one would rather assume an increase of PRC through inhibitory effects of 
ET-1 in Ren1d+/Cre-ETARfl/fl-ETBRfl/fl mice. 
However, present results support theory that both ET receptors seem to show no important 
direct effect via ET-1 on mediating renin synthesis and secretion expressed on renin 
producing cells in vivo.  
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Moreover, it has been shown, that alongside ET-1 other vasoconstrictive hormones such as 
ANG II, arginine vasopressin are also known as negative regulators of renin synthesis. The 
work at hand promote theories that these hormones mediate renin inhibition independently of 
ET system or ET-receptors located on other cells than renin cell lineage are more involved in 
regulating renin synthesis and secretion in vivo. The isolated perfused kidney experiments 
with Ren1d+/Cre-ETARfl/fl-ETBRfl/fl animals showed an inhibition of renin secretion mainly 
mediated by the reduction of renal blood flow after adding ET-1 to the ex situ system as in 
controls. After comparing current in vivo and in vitro results, one could assume that the ET-
system maybe more involved in short-term regulation of renin secretion and synthesis but 
seems of less relevance on a long-term basis.  
These results indicate the hypothesis that additional renal ET receptors than ETAR or ETBR 
are present on renin producing cells, although Maguire and Davenport concluded in 2015 
that there are still no evidences for this theory (Maguire and Davenport, 2015).  
However, it should be mentioned at this juncture that potential ET receptor heterodimers are 
still present in Ren1d+/Cre-ETARfl/fl-ETBRfl/fl animals unaffected by present Cre-recombinase 
activation. Perhaps, these heterodimers are able to bind ET-1 resulting in present in vivo 
data. In addition, Inscho et al., postulated in 2005, that either an ETA receptor selective or 
ETB-selective antagonist was able to abolish afferent arteriole vasoconstrictor responses to 
low concentrations of ET-1, which support given results of isolated perfused kidney data 
(Inscho et al., 2005; Boesen, 2008). Several findings promote given hypothesis of 
heterodimerization but the functional consequences in vivo remains an open field of future 
inquiry (Boesen, 2008).  
Nonetheless, present findings support previous results on ET receptors isoforms. Both 
receptors expressed on renin producing cells suggest no essential direct effect on renin 
synthesis and secretion. The role of both receptors expressed on renin cell lineage is 
additionally rather more important in terms of pathophysiology. Bosentan and macitentan are 
both approved mixed antagonists in the clinic (Davenport et al., 2016; Palmer, 2009; Patel 
and McKeage, 2014; Sidharta et al., 2015) and used for a variety of diseases including 
scleroderma renal crisis and pulmonary hypertension. 
However, present results indicate that both ET-receptors located on renin cell lineage are not 
able to promote this inhibiting effect on renin synthesis and secretion by themselves. 
Following chapter discusses if a combination of several renal cell types more likely display 
the inhibiting effect of endothelins through ETAR and ETBR. 
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4.4 The role of both ET-receptors expressed on stroma derived cells on 
renin synthesis and secretion in vivo 
Previous shown results indicate no essential direct effect of ET receptors localized on the 
renin cell lineage for renin synthesis and secretion in vivo. Since the RenCre-promotor is 
active in other renal cell types e.g. collecting duct cells during nephrogenesis (Castrop et al., 
2006) the question arises, if the renin cell lineage is not able to promote this effect by itself. 
Therefore the question must be, if other renal cell types, expressing both receptors, regulate 
the inhibiting effect of endothelins on renin synthesis and secretion in vivo. In order to 
characterize the role of ET-receptor on stroma derived cell lineage, animals with Cre 
activation under the control of FoxD1 promotor were paired with ETAR and ETBR loxP mice.  
In FoxD1Cre/+-ETARfl/fl-ETBRfl/fl animals both receptor isoforms were deleted not only on renin 
producing cells but also on mesangial cells, smooth muscle cells and interstitial cells 
(Sequeira-Lopez et al., 2015; Kobayashi et al., 2014). 
All Cre+ animals showed normal renin mRNA levels as in control littermates and developed 
normal renin producing cells at the juxtaglomerular cell apparatus. In addition, the plasma 
renin concentration was not significantly changed in FoxD1Cre/+-ETARfl/fl-ETBRfl/fl than in 
control littermates. Although levels were slightly diminished in knockout mice compared to 
controls but it should be noted that present results were not expected. One would estimate 
an increase during inhibitory effects of ET-1. 
Moreover, these results were supported by systolic blood pressure measurements. All 
FoxD1Cre/+-ETARfl/fl-ETBRfl/fl animals as well as the ET receptor isoform knockouts (FoxD1Cre/+-
ETARfl/fl [as shown in 3.2.4] and FoxD1Cre/+-ETBRfl/fl [data not shown]) revealed normal blood 
pressure values as in control animals. These results indicate that the potential indirect 
stroma derived cell-specific effect of endothelins via both ET-receptors on the renin system 
seems of less relevance for renin synthesis and secretion in vivo.  
In contrast, isolated perfused kidney experiments with FoxD1Cre/+-ETARfl/fl-ETBRfl/fl revealed 
no inhibition of renin secretion rate compared to controls (FoxD1Cre/+-ETARfl/fl, FoxD1Cre/+-
ETBRfl/fl) through ET-1. Moreover, the decline of the renal blood flow was abolished and 
revealed no clear drop as in controls after adding ET-1 in increasing concentrations.  
With respect to previous results regarding renin cell lineage, the isolated perfused mouse 
kidney technique is an ex vivo/in vitro model where one can study kidney function in the 
absence of systemic influences such as the blood pressure, autonomic nervous system or 
different hormones. After comparing obtained in vivo and ex vivo/in vitro data, one can 
assume that systemic effects might explain current in vivo results.  
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It should also be noted, that changes in the renal blood flow are mainly based on the 
vasoconstriction of the renal vasculature (i.e. afferent arteriole) but also on the 
vasoconstriction of mesangial cells. Besides renin producing cells, both receptors are 
present on vascular smooth muscle cells but also on mesangial cells in the stroma derived 
cell lineage. Therefore, additional studies in the future need to distinguish between those cell 
types to investigate further the inhibiting effect of endothelins on renin synthesis and 
secretion in vivo.  
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4.5. Outlook 
As mentioned above present results indicate that both ET receptors located on renin 
producing cell lineage seem to be of less relevance for the renin synthesis and secretion 
moreover for the physiological regulation of the renin system in vivo. The ETA and ETB-
receptor are also expressed on tubular structures (distal tubular structures and collecting 
duct cells) and maybe these cells are somehow involved in homeostasis of the extracellular 
volume and perhaps in ET-1 mediated inhibition of renin secretion and synthesis. Therefore, 
it would be a stringent approach to investigate the role of ET-receptors in mice with ETAR 
and/or ETBR deletion especially in tubular renal segments.  
ET-1 is suggested to primarily act through its ET-receptors in a Ca2+ dependent mechanism 
to inhibit renin release in vitro whereas studies indicate that the action is rather ETB-
mediated (Ritthaler et al., 1995). Recent experiments showed an increase in Ca2+ 
concentration when ET-1 was added to isolated renin positive cells of Ren1d+/Cre-ETARfl/fl 
kidneys loaded with Fura-2 suggesting that ETBR is able to compensate function when 
ETAR is deleted on renin producing cells (data not shown). More experiments need to be 
performed further to better understand the mechanism beyond. Moreover, the specific role of 
both ET receptors on the Ca2+-dependent mechanism of renin inhibition located on renin 
producing cells needs to be evaluated prospectively (Ren1d+/Cre-ETARfl/fl-ETBRfl/fl).  
Over the years, a number of studies focused on renal interstitial cells and their possible 
physiological functions. With respect to present findings, it is ETBR as part of the endothelin 
system which could be localized on renal interstitial cells. With the help of co-localization 
studies, one could reveal that PDGFRβ+ cells also express ETBR. However this 
phenomenon does not occur continuously in the kidney. In order to study a potential role of 
renal ETBR expressed on interstitial cells for renin synthesis and secretion in vivo, additional 
experiments are planned for the future (PDGFRβ+-Cre-ERT2-ETBRfl/fl). 
In terms of possible ET receptor dimerization and its effects on the renin system, Zeng and 
colleagues reported a possible ETB-Angiotensin type 1-receptor interaction in vitro (Zeng et 
al., 2005). Further in vivo investigations can examine possible renal physiological 
consequences located on renin producing cells with the help of an animal model (Ren1d+/Cre-
ETBRfl/fl-AT1afl/fl). Riggelmann et al., concluded that ET receptors antagonists are able to 
abolish acute and chronic effects of ANG II (Riggleman et al., 2001). Perhaps this receptor 
interaction can reveal more details about the influence of endothelin system on renal 
physiology and RAAS in general.  
The question arises, what is the function of the strong ET-receptors expression on renin 
producing cells. It is therefore possible to consider that both ET receptors seem to become 
Outlook 
92 
 
more relevant in terms of pathophysiology. Different studies indicate an involvement of the 
ET-system in sepsis, chronic kidney disease or cardiovascular diseases (Barton and 
Yanagisawa, 2008). In order to get a better understanding how and to what extend renal ET-
receptors located on renin producing cells are involved in situations of pathophysiology, it 
would be interesting to investigate the role of ET-receptors in renal disease models. In this 
context, recent data of our group showed a dramatic increase of ET-1 and ET-receptor 
mRNA levels during the progression of renal fibrosis. A future approach is to perform 
unilateral ureter obstruction (UUO) inducing renal fibrosis in Ren1d+/Cre-ETARfl/fl, Ren1d+/Cre-
ETBRfl/fl as well as in Ren1d+/Cre-ETARfl/fl-ETBRfl/fl animals. 
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5 Summary 
The protease renin is known as the central regulatory factor of the Renin-Angiotensin-
Aldosterone system. It is primarily synthesized in the kidney from juxtaglomerular epitheloid 
cells and is stored in secretory vesicles until release. The release of renin has been shown to 
be stimulated by cAMP signaling pathway and inhibited by an increase of cytosolic Ca2+ 
concentration. Several local and systemic factors including different vasoconstrictor 
hormones such as ANG II and arginine vasopressin have been shown to inhibit renin release 
from juxtaglomerular cells in the kidney. 
Moreover, endothelins have been demonstrated to attribute as inhibiting regulators of renin 
synthesis and secretion in vitro (Berthold et al., 1999; Scholz et al., 1995; Ritthaler et al., 
1995; Ritthaler et al., 1996; Ackermann et al., 1995). The endothelin system consists of three 
peptide hormones Endothelin-1, Endothelin-2 and Endothelin-3 and their G-protein coupled 
receptors Endothelin-A and Endothelin-B receptor. The endothelin system could be detected 
in different parts of the human body, including lung, heart, central nervous system and the 
kidney. Previous studies displayed Endothelin-1 as one of the potent vasoconstrictors in the 
renal vasculature whereas ET-1/ETAR signaling pathway is suggested to act as the main 
vasoconstrictor (Kaasjager et al., 1997; Bohm et al., 2003) while ETB-receptor, at least 
initially, causes vasodilation (Kohan et al., 2011a).  
The work at hand aimed to characterize the relevance of endothelins focusing on ET-1/ETA-
receptor and/or ETB-receptor signaling pathway for the physiological regulation of renin 
synthesis and secretion in vivo. Moreover, we addressed the question if the proven inhibiting 
effect on the renin system via ETAR and/or ETBR signaling pathway is accompanied by a 
direct effect located on the level of renin producing juxtaglomerular cells or through indirect 
effects based on renal stroma derived cells or on systemic or general effects. The first part 
concentrates on the potential effect of ET-1/ETAR signaling pathway on the renin system in 
vivo. For this purpose, a renin cell-specific ETAR animal model was generated (Ren1d+/Cre-
ETARfl/fl). More precisely, with the help of the Cre/loxP system, ETA-receptor could be 
deleted exclusively on renin producing cells to examine further its possible effects on the 
level of JG cells for renin synthesis and secretion in vivo. Due to a widely distribution of 
ETAR receptor expression in the kidney, it was ineluctable to further investigate if ETA-
receptors located on other renal cells display a potential indirect effect on the renin synthesis 
and secretion. In order to study, if the effect is based on stroma derived cells including renin 
producing cells, mesangial cells, vascular smooth muscle cells and interstitial cells 
(FOXD1Cre/+-ETARfl/fl) or through systemic (SMMHC-Cre-ERT2-ETARfl/fl) or general effects 
(CAGG-Cre-ERT2-ETARfl/fl) additional animal models were provided.  
Summary 
94 
 
The second part of present thesis concentrates on the potential effects of ET-1/ETBR 
isoform signaling pathway on the renin system in vivo. Therefore, the generation of a renin 
cell-specific ETBR animal model was necessary (Ren1d+/Cre-ETBRfl/fl) which was verified by in 
situ hybridization assay. In addition, further experiments aimed to characterize, if the possible 
inhibitory effect of ETBR isoform on renin synthesis and secretion is regulated by stroma 
derived cells (FOXD1Cre/+-ETBRfl/fl). 
With respect to present results of the first and second chapter, the renal ET-receptor 
isoforms seem to be of less relevance for the renin synthesis and secretion in vivo. All used 
animals showed normal developed renin positive cells, renin mRNA abundance, PRC values 
and unchanged systolic blood pressures compared to controls. In addition, all animals 
displayed an inhibition of renin secretion mainly mediated by a decline of the renal blood flow 
in the isolated perfused kidney model after adding ET-1 in increasing concentration to the ex 
vivo system. 
In order to exclude potential ET-receptors interactions on renin positive cells in vivo, a renin 
cell-specific ETAR and ETBR “double knockout” animal model (Ren1d+/Cre-ETARfl/fl-ETBRfl/fl) 
was generated in the last part of the present study. Several functional in vivo experiments 
were administered subsequently. All Cre+ animals showed normal renin mRNA abundance 
and unchanged systolic blood pressure values compared to controls. Only plasma renin 
concentration was slightly diminished in Ren1d+/Cre-ETARfl/fl-ETBRfl/fl compared to controls. In 
addition, all animals developed normal renin positive cells at the juxtaglomerular cell 
apparatus as in controls. The isolated perfused kidneys of Ren1d+/Cre-ETARfl/fl-ETBRfl/fl-mice 
revealed an inhibition of renin secretion rate mediated by the decline of the renal blood flow 
through ET-1 similar to control animals. All mentioned results indicate that both ET-receptors 
on renin producing cells seem to be of less importance for the renin synthesis and secretion 
moreover for the renin system in vivo and in vitro. It was assumed that renal ET-receptors 
expressed on other renal specific cells maybe more important for this regulation. Therefore, 
to further examine a potential indirect effect of ET-receptors on the renin system a stroma 
derived cell-specific “double knockout” animal model was generated (FOXD1Cre/+- ETARfl/fl-
ETBRfl/fl).  
All FOXD1Cre/+- ETARfl/fl-ETBRfl/fl animals displayed normal levels of renin mRNA and no 
significant changes in plasma renin concentrations compared to controls. These results were 
supported by systolic blood pressure measurements. Via the tail cuff method, one could 
detect that FOXD1Cre/+- ETARfl/fl-ETBRfl/fl mice had normal levels of blood pressure as shown 
in control littermates.  
Summary 
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In the absence of systemic influences, the isolated perfused kidney model displayed in 
FOXD1Cre/+- ETARfl/fl-ETBRfl/fl no inhibition of renin secretion and a nearly steady renal blood 
flow compared to controls. These results support theory that systemic effects such as the 
blood pressure, the autonomic nervous system or different hormones are maybe involved in 
present situation. Moreover, those effects seem to interact in current ET receptor deletion 
equilibrating homeostasis.  
In summary, present thesis indicate for the very first time that both ET-receptors are markers 
for renin producing cells. Moreover both ET-receptor isoforms seem to be not of major 
relevance for renin synthesis and secretion. There are findings which support theory of 
receptor interaction and that each single receptor isoform is able to take over functional role 
of the other receptor. Besides the potential direct effect, present thesis also focused on 
hypothesis that the inhibiting effect of endothelins on renin synthesis and secretion is 
regulated by ET receptors located on stroma derived cells (FOXD1Cre/+- ETARfl/fl-ETBRfl/fl). 
However after investigation, present results seem to refute given postulation because there 
were no significant changes in FOXD1Cre/+- ETARfl/fl-ETBRfl/fl mice regarding in vivo 
parameters compared to controls. All animals developed normal renin producing cells as in 
controls.  
The inhibiting effect of endothelins on renin synthesis and secretion is therefore not primarily 
mediated by either renin cell lineage or stroma derived cells. Present results indicate that 
systemic effects are more involved in the regulation of the renin system or other expression 
sites as for example mesangial cells or tubular structures are possible to regulate the 
inhibition of renin secretion and synthesis through endothelins. Further investigations need to 
evaluate prospectively, if ET-receptors located on renin producing cells are more involved in 
terms of situations of pathophysiology.  
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7 Supplement 
7.1 List of abbreviations 
°C  degree Celsius 
µl  microliter 
µm  micrometer 
∞  unlimited 
A  ampere 
a  adenine 
aa  afferent arteriole 
ANG-I  angiotensin-I 
ANG-II  angiotensin-II 
AQP2  aquaporine-2 
ca.  circa 
CAGG  
(C) cytomegalovirus (CMV) early 
enhancer element 
(A) the promoter, first exon and 
the intron of chicken beta-actin 
(G) the splice acceptor of the 
rabbot beta globin gene 
CD31  
cluster of differentiation 31 
(PECAM-1) 
cDNA  complementary DNA 
ch  chicken 
Cre/loxP   
Cre-ERT2  
fusion protein consisting of Cre-
recombinase and modified 
estrogen binding site 
d  days 
dH2O  distilled water 
dk  donkey 
DMEM  
Dulbecco’s Modified Eagle 
Medium 
ECE  endothelin-converting enzyme 
ECE  endothelin-converting enzymes 
ELISA  
enzyme-linked immunosorbent 
assay 
et al. 
 
 
and others 
 
ET-1  endothelin-1 
ET-2  endothelin-2 
ET-3  endothelin-3 
ETAR 
 
 
endothelin-A receptor 
 
ETBR  endothelin-B receptor 
Fig.  Figure 
FOXD1  forkhead box D1 
GAPDH  
Glycerinaldehyd-3-phosphat-
Dehydrogenase 
GFP  green fluorescent protein 
gt  goat 
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h  hours, human 
i.e  for example 
IPMK  isolated perfused kidney model 
ISH  in situ hybridization 
iso  isoproterenol 
JG  juxtaglomerular 
L  liter 
LD  loading dye 
M  molar (mol/L) 
mA  milliampere 
min  minute 
ml  milliliter 
mRNA  messenger ribonucleic acid 
ms  mouse 
ng  nanogram 
nm  nanometer 
ON  over night 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
PE  polyethylene 
PFA  paraformaldehyde 
prepro-ET  prepro-endothelins 
RAAS  
Renin-Angiotensin-Aldosterone 
system 
rb  rabbit 
rpcs  renin producing cells 
RPL32  ribosomal protein L32 
rpm  revolutions per minute 
RS  renin system 
RT  
reverse transcription,  
room temperature 
SMMHC  
Smooth muscle myosin, heavy 
chain (myosin-11 or SMMHC) 
TAE  Tris acetate EDTA buffer 
Taq Polymerase 
 
 
thermostable DNA polymerase 
named after Thermus aquaticus 
 
Tris  tris hydroxymethyl aminomethan 
TRITC  
Tetramethylrhodamine 
isothiocyanate 
V  volt 
W  watt 
WT  wildtype 
α  anti or alpha 
α-sma  α-smooth muscle actin 
β  beta 
μ  micro (10^-6) 
 
The knowledge of the chemical elements and SI units as well as usually used abbreviations 
in science or medicine was assumed. 
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7.2 Congress contributions 
95th Annual Meeting of the German Physiological Society, 02.03.-05.03.2016, Lübeck, 
Germany – poster 
“The endothelin-A receptor is expressed by renin cells of the kidney but is of less relevance 
for the physiological control of renin synthesis and secretion” 
 
8th Annual Meeting of the “Deutschen Gesellschaft für Nephrologie”, 10.09.-13.09.2016, 
Berlin, Germany – poster  
“Die Rolle des Endothelin-1/Endothelin-A-Rezeptor Signalweges für die Regulation des 
Reninsystems in der Mausniere” 
 
96th Annual Meeting of the German Physiological Society, 16.03.-18.03.2017, Greifswald, 
Germany – poster 
“The endothelin-A and endothelin-B receptor are expressed by renin cells of the kidney but 
seem to be of less relevance for the physiological control of renin synthesis and secretion in 
vivo 
 
The Fifteenth International Conference on Endothelin, 4.10.-7.10.2017, Prague, Czech 
Republic - talk 
“Is the inhibiting effect of endothelins on renin synthesis and secretion a direct effect on renin 
producing cells?” 
 
7.3 Publications 
Role of ET-receptors in the renin cell lineage for renin synthesis and secretion in vivo and in 
vitro  
Neder TH, Neubauer B, Epstein M, Gomez RA, Yanagisawa M, Kurtz A, Wagner C: (in prep) 
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